| ENSG00000179859.7 |
IPA-3 |
Bladder urothelial carcinoma |
0.006982399 |
Resistant |
| ENSG00000204802.3 |
IPA-3 |
Bladder urothelial carcinoma |
0.048860202 |
Resistant |
| ENSG00000204837.2 |
IPA-3 |
Bladder urothelial carcinoma |
0.031606842 |
Resistant |
| ENSG00000223546.2 |
IPA-3 |
Bladder urothelial carcinoma |
0.005778551 |
Resistant |
| ENSG00000223969.1 |
IPA-3 |
Bladder urothelial carcinoma |
0.049771336 |
Resistant |
| ENSG00000224281.4 |
IPA-3 |
Bladder urothelial carcinoma |
0.017042519 |
Resistant |
| ENSG00000225075.1 |
IPA-3 |
Bladder urothelial carcinoma |
0.045713008 |
Resistant |
| ENSG00000225733.1 |
IPA-3 |
Bladder urothelial carcinoma |
0.005948845 |
Resistant |
| ENSG00000227627.1 |
IPA-3 |
Bladder urothelial carcinoma |
0.033301785 |
Resistant |
| ENSG00000227857.2 |
IPA-3 |
Bladder urothelial carcinoma |
0.034607382 |
Resistant |
| ENSG00000228350.1 |
IPA-3 |
Bladder urothelial carcinoma |
0.035158186 |
Resistant |
| ENSG00000228386.2 |
IPA-3 |
Bladder urothelial carcinoma |
0.015234493 |
Resistant |
| ENSG00000229582.2 |
IPA-3 |
Bladder urothelial carcinoma |
0.014357722 |
Resistant |
| ENSG00000230530.1 |
IPA-3 |
Bladder urothelial carcinoma |
0.043456116 |
Resistant |
| ENSG00000232412.1 |
IPA-3 |
Bladder urothelial carcinoma |
0.003946093 |
Resistant |
| ENSG00000232611.1 |
IPA-3 |
Bladder urothelial carcinoma |
0.045295274 |
Resistant |
| ENSG00000234160.1 |
IPA-3 |
Bladder urothelial carcinoma |
0.031325643 |
Resistant |
| ENSG00000234183.1 |
IPA-3 |
Bladder urothelial carcinoma |
0.029116839 |
Resistant |
| ENSG00000235159.1 |
IPA-3 |
Bladder urothelial carcinoma |
0.014157873 |
Resistant |
| ENSG00000235214.1 |
IPA-3 |
Bladder urothelial carcinoma |
0.034975498 |
Resistant |
| ENSG00000235423.4 |
IPA-3 |
Bladder urothelial carcinoma |
0.03641566 |
Resistant |
| ENSG00000236499.2 |
IPA-3 |
Bladder urothelial carcinoma |
0.033545356 |
Resistant |
| ENSG00000237594.2 |
IPA-3 |
Bladder urothelial carcinoma |
0.04991643 |
Resistant |
| ENSG00000237903.1 |
IPA-3 |
Bladder urothelial carcinoma |
0.045237499 |
Resistant |
| ENSG00000238123.1 |
IPA-3 |
Bladder urothelial carcinoma |
0.033949656 |
Resistant |
| ENSG00000239407.1 |
IPA-3 |
Bladder urothelial carcinoma |
0.010970376 |
Resistant |
| ENSG00000244184.1 |
IPA-3 |
Bladder urothelial carcinoma |
0.011295693 |
Resistant |
| ENSG00000244926.2 |
IPA-3 |
Bladder urothelial carcinoma |
0.029911687 |
Resistant |
| ENSG00000246308.1 |
IPA-3 |
Bladder urothelial carcinoma |
0.04642801 |
Resistant |
| ENSG00000246323.2 |
IPA-3 |
Bladder urothelial carcinoma |
0.040938945 |
Resistant |
| ENSG00000248489.1 |
IPA-3 |
Bladder urothelial carcinoma |
0.04159336 |
Resistant |
| ENSG00000248668.1 |
IPA-3 |
Bladder urothelial carcinoma |
0.027199895 |
Resistant |
| ENSG00000250234.1 |
IPA-3 |
Bladder urothelial carcinoma |
0.025163387 |
Resistant |
| ENSG00000250900.2 |
IPA-3 |
Bladder urothelial carcinoma |
0.018932428 |
Resistant |
| ENSG00000251555.1 |
IPA-3 |
Bladder urothelial carcinoma |
0.017126513 |
Resistant |
| ENSG00000253730.1 |
IPA-3 |
Bladder urothelial carcinoma |
0.037647706 |
Resistant |
| ENSG00000257167.2 |
IPA-3 |
Bladder urothelial carcinoma |
0.041027764 |
Resistant |
| ENSG00000257285.1 |
IPA-3 |
Bladder urothelial carcinoma |
0.019306803 |
Resistant |
| ENSG00000257660.1 |
IPA-3 |
Bladder urothelial carcinoma |
0.048338065 |
Resistant |
| ENSG00000257815.1 |
IPA-3 |
Bladder urothelial carcinoma |
0.035431592 |
Resistant |
| ENSG00000259563.1 |
IPA-3 |
Bladder urothelial carcinoma |
0.043688575 |
Resistant |
| ENSG00000259804.1 |
IPA-3 |
Bladder urothelial carcinoma |
0.031638924 |
Resistant |
| ENSG00000259826.1 |
IPA-3 |
Bladder urothelial carcinoma |
0.044067055 |
Resistant |
| ENSG00000260273.1 |
IPA-3 |
Bladder urothelial carcinoma |
0.039001651 |
Resistant |
| ENSG00000260495.1 |
IPA-3 |
Bladder urothelial carcinoma |
0.03720841 |
Resistant |
| ENSG00000260572.1 |
IPA-3 |
Bladder urothelial carcinoma |
0.000397997 |
Resistant |
| ENSG00000260664.1 |
IPA-3 |
Bladder urothelial carcinoma |
0.023875004 |
Resistant |
| ENSG00000260954.1 |
IPA-3 |
Bladder urothelial carcinoma |
0.045960993 |
Resistant |
| ENSG00000261008.2 |
IPA-3 |
Bladder urothelial carcinoma |
0.017825986 |
Resistant |
| ENSG00000261242.1 |
IPA-3 |
Bladder urothelial carcinoma |
0.049397081 |
Resistant |
| ENSG00000261485.1 |
IPA-3 |
Bladder urothelial carcinoma |
0.030871616 |
Resistant |
| ENSG00000263105.1 |
IPA-3 |
Bladder urothelial carcinoma |
0.00299873 |
Resistant |
| ENSG00000266079.2 |
IPA-3 |
Bladder urothelial carcinoma |
0.009878035 |
Resistant |
| ENSG00000267374.1 |
IPA-3 |
Bladder urothelial carcinoma |
0.019434726 |
Resistant |
| ENSG00000268471.3 |
IPA-3 |
Bladder urothelial carcinoma |
0.035720082 |
Resistant |
| ENSG00000269473.1 |
IPA-3 |
Bladder urothelial carcinoma |
0.048139573 |
Resistant |
| ENSG00000269814.1 |
IPA-3 |
Bladder urothelial carcinoma |
0.046947567 |
Resistant |
| ENSG00000270130.1 |
IPA-3 |
Bladder urothelial carcinoma |
0.036013579 |
Resistant |
| ENSG00000270820.1 |
IPA-3 |
Bladder urothelial carcinoma |
0.002708318 |
Resistant |
| ENSG00000270964.1 |
IPA-3 |
Bladder urothelial carcinoma |
0.003254889 |
Resistant |
| ENSG00000271646.1 |
IPA-3 |
Bladder urothelial carcinoma |
0.019522883 |
Resistant |
| ENSG00000271751.1 |
IPA-3 |
Bladder urothelial carcinoma |
0.017041149 |
Resistant |
| ENSG00000271869.1 |
IPA-3 |
Bladder urothelial carcinoma |
0.028329863 |
Resistant |
| ENSG00000271991.1 |
IPA-3 |
Bladder urothelial carcinoma |
0.044600235 |
Resistant |
| ENSG00000272248.1 |
IPA-3 |
Bladder urothelial carcinoma |
0.036129491 |
Resistant |
| ENSG00000272525.1 |
IPA-3 |
Bladder urothelial carcinoma |
0.008179896 |
Resistant |
| ENSG00000272567.1 |
IPA-3 |
Bladder urothelial carcinoma |
0.021754604 |
Resistant |
| ENSG00000272691.1 |
IPA-3 |
Bladder urothelial carcinoma |
0.012528055 |
Resistant |
| ENSG00000273004.1 |
IPA-3 |
Bladder urothelial carcinoma |
0.011230705 |
Resistant |
| ENSG00000273162.1 |
IPA-3 |
Bladder urothelial carcinoma |
0.033229927 |
Resistant |
| ENSG00000273181.1 |
IPA-3 |
Bladder urothelial carcinoma |
0.037158031 |
Resistant |
| ENSG00000231830.1 |
IPA-3 |
Breast invasive carcinoma |
0.043228158 |
Resistant |
| ENSG00000235802.1 |
IPA-3 |
Breast invasive carcinoma |
0.048533729 |
Resistant |
| ENSG00000237253.1 |
IPA-3 |
Breast invasive carcinoma |
0.015072519 |
Resistant |
| ENSG00000237343.1 |
IPA-3 |
Breast invasive carcinoma |
0.03375021 |
Resistant |
| ENSG00000248758.1 |
IPA-3 |
Breast invasive carcinoma |
0.032480048 |
Resistant |
| ENSG00000253720.1 |
IPA-3 |
Breast invasive carcinoma |
0.012204996 |
Resistant |
| ENSG00000254662.1 |
IPA-3 |
Breast invasive carcinoma |
0.046597207 |
Resistant |
| ENSG00000258486.2 |
IPA-3 |
Breast invasive carcinoma |
0.004046145 |
Resistant |
| ENSG00000260929.1 |
IPA-3 |
Breast invasive carcinoma |
0.043120382 |
Resistant |
| ENSG00000264222.1 |
IPA-3 |
Breast invasive carcinoma |
0.016849745 |
Resistant |
| ENSG00000267549.1 |
IPA-3 |
Breast invasive carcinoma |
0.03924896 |
Resistant |
| ENSG00000268375.1 |
IPA-3 |
Breast invasive carcinoma |
0.014733324 |
Resistant |
| ENSG00000269896.1 |
IPA-3 |
Breast invasive carcinoma |
0.044199895 |
Resistant |
| ENSG00000273176.1 |
IPA-3 |
Breast invasive carcinoma |
0.038405556 |
Resistant |
| ENSG00000203585.3 |
IPA-3 |
Colon adenocarcinoma |
0.031942327 |
Resistant |
| ENSG00000233559.1 |
IPA-3 |
Colon adenocarcinoma |
0.016271877 |
Resistant |
| ENSG00000233864.3 |
IPA-3 |
Colon adenocarcinoma |
0.005414737 |
Resistant |
| ENSG00000251387.1 |
IPA-3 |
Colon adenocarcinoma |
0.016408037 |
Resistant |
| ENSG00000251665.1 |
IPA-3 |
Colon adenocarcinoma |
0.017973334 |
Resistant |
| ENSG00000254854.1 |
IPA-3 |
Colon adenocarcinoma |
0.014976348 |
Resistant |
| ENSG00000125804.9 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.041118382 |
Resistant |
| ENSG00000215241.3 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.006606403 |
Resistant |
| ENSG00000215458.4 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.003446358 |
Resistant |
| ENSG00000224577.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.019768448 |
Resistant |
| ENSG00000224789.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.001730404 |
Resistant |
| ENSG00000225075.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.000462036 |
Resistant |
| ENSG00000227512.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.032724148 |
Resistant |
| ENSG00000227888.3 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.036977071 |
Resistant |
| ENSG00000228786.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.042625993 |
Resistant |
| ENSG00000229162.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.002536352 |
Resistant |
| ENSG00000229263.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.0000763 |
Resistant |
| ENSG00000229431.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.003825518 |
Resistant |
| ENSG00000229951.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.002452753 |
Resistant |
| ENSG00000229955.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.0162905 |
Resistant |
| ENSG00000230013.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.029644068 |
Resistant |
| ENSG00000230303.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.000291242 |
Resistant |
| ENSG00000230724.5 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.007491423 |
Resistant |
| ENSG00000230815.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.02153983 |
Resistant |
| ENSG00000230922.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.003473554 |
Resistant |
| ENSG00000231193.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.003373938 |
Resistant |
| ENSG00000231616.4 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.021725515 |
Resistant |
| ENSG00000232542.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.020740509 |
Resistant |
| ENSG00000232729.3 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.014955743 |
Resistant |
| ENSG00000233937.2 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.035843566 |
Resistant |
| ENSG00000235770.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.03638976 |
Resistant |
| ENSG00000236703.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.023208003 |
Resistant |
| ENSG00000237094.7 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.001326871 |
Resistant |
| ENSG00000237424.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.008900815 |
Resistant |
| ENSG00000237903.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.001876761 |
Resistant |
| ENSG00000238035.4 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.000641923 |
Resistant |
| ENSG00000239552.2 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.04512624 |
Resistant |
| ENSG00000239906.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.009923478 |
Resistant |
| ENSG00000242154.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.038064162 |
Resistant |
| ENSG00000246331.2 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.01340862 |
Resistant |
| ENSG00000249740.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.017842562 |
Resistant |
| ENSG00000251127.2 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.013387691 |
Resistant |
| ENSG00000251148.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.006067926 |
Resistant |
| ENSG00000253385.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.016752298 |
Resistant |
| ENSG00000253741.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.011999265 |
Resistant |
| ENSG00000254237.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.018054509 |
Resistant |
| ENSG00000255557.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.0000831 |
Resistant |
| ENSG00000255928.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.017229388 |
Resistant |
| ENSG00000256299.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.008740958 |
Resistant |
| ENSG00000256712.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.047682002 |
Resistant |
| ENSG00000257759.2 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.01813942 |
Resistant |
| ENSG00000258428.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.02561306 |
Resistant |
| ENSG00000258733.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.013827424 |
Resistant |
| ENSG00000258940.2 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.042065525 |
Resistant |
| ENSG00000259081.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.009155661 |
Resistant |
| ENSG00000259187.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.021446517 |
Resistant |
| ENSG00000259230.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.003498052 |
Resistant |
| ENSG00000259376.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.036861236 |
Resistant |
| ENSG00000259474.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.022198755 |
Resistant |
| ENSG00000260032.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.030296142 |
Resistant |
| ENSG00000260805.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.020115388 |
Resistant |
| ENSG00000261216.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.03221092 |
Resistant |
| ENSG00000262952.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.036300636 |
Resistant |
| ENSG00000263934.2 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.017526614 |
Resistant |
| ENSG00000266088.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.026780676 |
Resistant |
| ENSG00000266498.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.030545688 |
Resistant |
| ENSG00000266901.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.042440465 |
Resistant |
| ENSG00000267159.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.001190633 |
Resistant |
| ENSG00000267502.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.007280814 |
Resistant |
| ENSG00000267658.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.021773771 |
Resistant |
| ENSG00000269191.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.029152885 |
Resistant |
| ENSG00000269486.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.0000782 |
Resistant |
| ENSG00000269906.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.003014309 |
Resistant |
| ENSG00000269925.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.010854032 |
Resistant |
| ENSG00000270048.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043681172 |
Resistant |
| ENSG00000270130.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.047844387 |
Resistant |
| ENSG00000270681.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.003874572 |
Resistant |
| ENSG00000271020.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.000261258 |
Resistant |
| ENSG00000271324.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.009248718 |
Resistant |
| ENSG00000271590.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.00121685 |
Resistant |
| ENSG00000271643.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.020067307 |
Resistant |
| ENSG00000271788.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.008404845 |
Resistant |
| ENSG00000271835.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.008494764 |
Resistant |
| ENSG00000271845.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.012234561 |
Resistant |
| ENSG00000272183.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.046143638 |
Resistant |
| ENSG00000272544.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.046755905 |
Resistant |
| ENSG00000272702.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.005923194 |
Resistant |
| ENSG00000273014.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.003306 |
Resistant |
| ENSG00000273319.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.045549364 |
Resistant |
| ENSG00000180139.10 |
IPA-3 |
Esophageal cancer |
0.003109472 |
Resistant |
| ENSG00000185837.3 |
IPA-3 |
Esophageal cancer |
0.017713331 |
Resistant |
| ENSG00000186019.10 |
IPA-3 |
Esophageal cancer |
0.046827909 |
Resistant |
| ENSG00000203288.3 |
IPA-3 |
Esophageal cancer |
0.009395591 |
Resistant |
| ENSG00000203496.4 |
IPA-3 |
Esophageal cancer |
0.013949607 |
Resistant |
| ENSG00000211683.3 |
IPA-3 |
Esophageal cancer |
0.018647947 |
Resistant |
| ENSG00000215190.4 |
IPA-3 |
Esophageal cancer |
0.003468471 |
Resistant |
| ENSG00000215256.3 |
IPA-3 |
Esophageal cancer |
0.005153241 |
Resistant |
| ENSG00000224174.2 |
IPA-3 |
Esophageal cancer |
0.037576499 |
Resistant |
| ENSG00000224541.1 |
IPA-3 |
Esophageal cancer |
0.027722195 |
Resistant |
| ENSG00000224638.1 |
IPA-3 |
Esophageal cancer |
0.003430282 |
Resistant |
| ENSG00000225745.4 |
IPA-3 |
Esophageal cancer |
0.025495011 |
Resistant |
| ENSG00000226472.3 |
IPA-3 |
Esophageal cancer |
0.000458007 |
Resistant |
| ENSG00000226699.1 |
IPA-3 |
Esophageal cancer |
0.025068665 |
Resistant |
| ENSG00000227945.1 |
IPA-3 |
Esophageal cancer |
0.028460635 |
Resistant |
| ENSG00000228293.1 |
IPA-3 |
Esophageal cancer |
0.028180526 |
Resistant |
| ENSG00000228315.7 |
IPA-3 |
Esophageal cancer |
0.037489085 |
Resistant |
| ENSG00000228323.2 |
IPA-3 |
Esophageal cancer |
0.037215278 |
Resistant |
| ENSG00000228350.1 |
IPA-3 |
Esophageal cancer |
0.003283594 |
Resistant |
| ENSG00000228889.2 |
IPA-3 |
Esophageal cancer |
0.046064481 |
Resistant |
| ENSG00000230487.3 |
IPA-3 |
Esophageal cancer |
0.000181531 |
Resistant |
| ENSG00000230606.6 |
IPA-3 |
Esophageal cancer |
0.011784045 |
Resistant |
| ENSG00000230836.1 |
IPA-3 |
Esophageal cancer |
0.022226933 |
Resistant |
| ENSG00000231611.1 |
IPA-3 |
Esophageal cancer |
0.049394876 |
Resistant |
| ENSG00000232455.2 |
IPA-3 |
Esophageal cancer |
0.017863386 |
Resistant |
| ENSG00000232995.3 |
IPA-3 |
Esophageal cancer |
0.026453998 |
Resistant |
| ENSG00000233230.1 |
IPA-3 |
Esophageal cancer |
0.010625482 |
Resistant |
| ENSG00000234318.1 |
IPA-3 |
Esophageal cancer |
0.030984932 |
Resistant |
| ENSG00000234456.3 |
IPA-3 |
Esophageal cancer |
0.036285321 |
Resistant |
| ENSG00000235445.1 |
IPA-3 |
Esophageal cancer |
0.007458771 |
Resistant |
| ENSG00000235477.2 |
IPA-3 |
Esophageal cancer |
0.045955164 |
Resistant |
| ENSG00000236377.1 |
IPA-3 |
Esophageal cancer |
0.036652929 |
Resistant |
| ENSG00000236559.1 |
IPA-3 |
Esophageal cancer |
0.046532976 |
Resistant |
| ENSG00000237476.1 |
IPA-3 |
Esophageal cancer |
0.033545481 |
Resistant |
| ENSG00000237491.4 |
IPA-3 |
Esophageal cancer |
0.002708235 |
Resistant |
| ENSG00000238058.1 |
IPA-3 |
Esophageal cancer |
0.008332502 |
Resistant |
| ENSG00000238068.1 |
IPA-3 |
Esophageal cancer |
0.01204497 |
Resistant |
| ENSG00000239467.1 |
IPA-3 |
Esophageal cancer |
0.000143248 |
Resistant |
| ENSG00000240731.1 |
IPA-3 |
Esophageal cancer |
0.003897847 |
Resistant |
| ENSG00000240758.2 |
IPA-3 |
Esophageal cancer |
0.008540022 |
Resistant |
| ENSG00000241481.2 |
IPA-3 |
Esophageal cancer |
0.011385512 |
Resistant |
| ENSG00000244161.1 |
IPA-3 |
Esophageal cancer |
0.040648445 |
Resistant |
| ENSG00000245573.3 |
IPA-3 |
Esophageal cancer |
0.045045646 |
Resistant |
| ENSG00000249602.1 |
IPA-3 |
Esophageal cancer |
0.005085907 |
Resistant |
| ENSG00000249996.1 |
IPA-3 |
Esophageal cancer |
0.008254148 |
Resistant |
| ENSG00000250069.1 |
IPA-3 |
Esophageal cancer |
0.002736234 |
Resistant |
| ENSG00000251523.1 |
IPA-3 |
Esophageal cancer |
0.02078248 |
Resistant |
| ENSG00000253741.1 |
IPA-3 |
Esophageal cancer |
0.027724652 |
Resistant |
| ENSG00000253917.3 |
IPA-3 |
Esophageal cancer |
0.022943655 |
Resistant |
| ENSG00000254485.1 |
IPA-3 |
Esophageal cancer |
0.030403301 |
Resistant |
| ENSG00000255337.1 |
IPA-3 |
Esophageal cancer |
0.044632137 |
Resistant |
| ENSG00000255989.1 |
IPA-3 |
Esophageal cancer |
0.031061017 |
Resistant |
| ENSG00000258561.1 |
IPA-3 |
Esophageal cancer |
0.017328893 |
Resistant |
| ENSG00000259200.1 |
IPA-3 |
Esophageal cancer |
0.000556005 |
Resistant |
| ENSG00000260368.1 |
IPA-3 |
Esophageal cancer |
0.036971828 |
Resistant |
| ENSG00000260498.1 |
IPA-3 |
Esophageal cancer |
0.009390076 |
Resistant |
| ENSG00000260630.2 |
IPA-3 |
Esophageal cancer |
0.026725166 |
Resistant |
| ENSG00000260698.1 |
IPA-3 |
Esophageal cancer |
0.009141172 |
Resistant |
| ENSG00000260977.1 |
IPA-3 |
Esophageal cancer |
0.031905821 |
Resistant |
| ENSG00000261019.1 |
IPA-3 |
Esophageal cancer |
0.004323829 |
Resistant |
| ENSG00000261135.1 |
IPA-3 |
Esophageal cancer |
0.007342959 |
Resistant |
| ENSG00000261324.2 |
IPA-3 |
Esophageal cancer |
0.035045715 |
Resistant |
| ENSG00000261455.1 |
IPA-3 |
Esophageal cancer |
0.030066266 |
Resistant |
| ENSG00000261490.1 |
IPA-3 |
Esophageal cancer |
0.017539303 |
Resistant |
| ENSG00000261716.1 |
IPA-3 |
Esophageal cancer |
0.043540765 |
Resistant |
| ENSG00000262202.3 |
IPA-3 |
Esophageal cancer |
0.028328257 |
Resistant |
| ENSG00000263627.1 |
IPA-3 |
Esophageal cancer |
0.001126421 |
Resistant |
| ENSG00000264672.1 |
IPA-3 |
Esophageal cancer |
0.0000608 |
Resistant |
| ENSG00000266993.1 |
IPA-3 |
Esophageal cancer |
0.022282663 |
Resistant |
| ENSG00000267042.1 |
IPA-3 |
Esophageal cancer |
0.024618994 |
Resistant |
| ENSG00000267213.3 |
IPA-3 |
Esophageal cancer |
0.049112428 |
Resistant |
| ENSG00000267737.1 |
IPA-3 |
Esophageal cancer |
0.010654096 |
Resistant |
| ENSG00000269148.1 |
IPA-3 |
Esophageal cancer |
0.000147431 |
Resistant |
| ENSG00000269815.1 |
IPA-3 |
Esophageal cancer |
0.017741977 |
Resistant |
| ENSG00000269867.1 |
IPA-3 |
Esophageal cancer |
0.031980408 |
Resistant |
| ENSG00000270210.1 |
IPA-3 |
Esophageal cancer |
0.049026722 |
Resistant |
| ENSG00000270344.1 |
IPA-3 |
Esophageal cancer |
0.032852704 |
Resistant |
| ENSG00000272024.1 |
IPA-3 |
Esophageal cancer |
0.039998889 |
Resistant |
| ENSG00000272092.1 |
IPA-3 |
Esophageal cancer |
0.022458431 |
Resistant |
| ENSG00000272361.1 |
IPA-3 |
Esophageal cancer |
0.048132551 |
Resistant |
| ENSG00000272677.1 |
IPA-3 |
Esophageal cancer |
0.048648487 |
Resistant |
| ENSG00000272848.1 |
IPA-3 |
Esophageal cancer |
0.010298391 |
Resistant |
| ENSG00000272954.1 |
IPA-3 |
Esophageal cancer |
0.0151668 |
Resistant |
| ENSG00000273007.1 |
IPA-3 |
Esophageal cancer |
0.005937672 |
Resistant |
| ENSG00000273026.1 |
IPA-3 |
Esophageal cancer |
0.042142845 |
Resistant |
| ENSG00000273108.1 |
IPA-3 |
Esophageal cancer |
0.037747626 |
Resistant |
| ENSG00000273270.1 |
IPA-3 |
Esophageal cancer |
0.029578361 |
Resistant |
| ENSG00000273284.1 |
IPA-3 |
Esophageal cancer |
0.003364915 |
Resistant |
| ENSG00000273492.1 |
IPA-3 |
Esophageal cancer |
0.029504701 |
Resistant |
| ENSG00000185904.7 |
IPA-3 |
Head and neck squamous cell carcinoma |
0.042595361 |
Resistant |
| ENSG00000187156.4 |
IPA-3 |
Head and neck squamous cell carcinoma |
0.017260289 |
Resistant |
| ENSG00000224259.1 |
IPA-3 |
Head and neck squamous cell carcinoma |
0.042394213 |
Resistant |
| ENSG00000227741.1 |
IPA-3 |
Head and neck squamous cell carcinoma |
0.024966231 |
Resistant |
| ENSG00000231683.2 |
IPA-3 |
Head and neck squamous cell carcinoma |
0.002573312 |
Resistant |
| ENSG00000231969.1 |
IPA-3 |
Head and neck squamous cell carcinoma |
0.043958225 |
Resistant |
| ENSG00000233554.1 |
IPA-3 |
Head and neck squamous cell carcinoma |
0.033043916 |
Resistant |
| ENSG00000235070.3 |
IPA-3 |
Head and neck squamous cell carcinoma |
0.021570784 |
Resistant |
| ENSG00000245522.2 |
IPA-3 |
Head and neck squamous cell carcinoma |
0.046386261 |
Resistant |
| ENSG00000253327.2 |
IPA-3 |
Head and neck squamous cell carcinoma |
0.034703585 |
Resistant |
| ENSG00000254602.1 |
IPA-3 |
Head and neck squamous cell carcinoma |
0.02875117 |
Resistant |
| ENSG00000255164.1 |
IPA-3 |
Head and neck squamous cell carcinoma |
0.012325938 |
Resistant |
| ENSG00000255240.1 |
IPA-3 |
Head and neck squamous cell carcinoma |
0.041389868 |
Resistant |
| ENSG00000260936.1 |
IPA-3 |
Head and neck squamous cell carcinoma |
0.034631213 |
Resistant |
| ENSG00000264569.1 |
IPA-3 |
Head and neck squamous cell carcinoma |
0.013961219 |
Resistant |
| ENSG00000267655.1 |
IPA-3 |
Head and neck squamous cell carcinoma |
0.028844484 |
Resistant |
| ENSG00000272273.1 |
IPA-3 |
Head and neck squamous cell carcinoma |
0.03756981 |
Resistant |
| ENSG00000196960.3 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.02599866 |
Resistant |
| ENSG00000224468.3 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.048155601 |
Resistant |
| ENSG00000225535.2 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.000599895 |
Resistant |
| ENSG00000226167.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.032308321 |
Resistant |
| ENSG00000226367.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.038097708 |
Resistant |
| ENSG00000227200.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.025163066 |
Resistant |
| ENSG00000227484.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.006583063 |
Resistant |
| ENSG00000227502.2 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.021045281 |
Resistant |
| ENSG00000228251.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.011334588 |
Resistant |
| ENSG00000229162.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.006021319 |
Resistant |
| ENSG00000229512.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.043832447 |
Resistant |
| ENSG00000232295.3 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.045562251 |
Resistant |
| ENSG00000232807.2 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.032035359 |
Resistant |
| ENSG00000233665.4 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.015958506 |
Resistant |
| ENSG00000234147.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.031713353 |
Resistant |
| ENSG00000234149.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.023492786 |
Resistant |
| ENSG00000234535.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.033470992 |
Resistant |
| ENSG00000234572.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.028849244 |
Resistant |
| ENSG00000234650.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.022245763 |
Resistant |
| ENSG00000235131.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.036618753 |
Resistant |
| ENSG00000236472.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.033587219 |
Resistant |
| ENSG00000237281.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.012139473 |
Resistant |
| ENSG00000237797.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.046135192 |
Resistant |
| ENSG00000238039.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.011621328 |
Resistant |
| ENSG00000240476.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.043539076 |
Resistant |
| ENSG00000241577.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.013972471 |
Resistant |
| ENSG00000241772.2 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.035111205 |
Resistant |
| ENSG00000244198.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.027410172 |
Resistant |
| ENSG00000244479.2 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.018227117 |
Resistant |
| ENSG00000247624.2 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.002221396 |
Resistant |
| ENSG00000249252.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.02954342 |
Resistant |
| ENSG00000251136.4 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.048633112 |
Resistant |
| ENSG00000253210.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.005276744 |
Resistant |
| ENSG00000254826.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.030940818 |
Resistant |
| ENSG00000255182.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.026888789 |
Resistant |
| ENSG00000255247.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.000122083 |
Resistant |
| ENSG00000258730.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.008508141 |
Resistant |
| ENSG00000259188.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.019610996 |
Resistant |
| ENSG00000259415.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.036340353 |
Resistant |
| ENSG00000261346.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.048825539 |
Resistant |
| ENSG00000261416.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.047553394 |
Resistant |
| ENSG00000261442.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.013042968 |
Resistant |
| ENSG00000267285.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.046120471 |
Resistant |
| ENSG00000267519.2 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.002089579 |
Resistant |
| ENSG00000267764.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.029727111 |
Resistant |
| ENSG00000272071.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.04453769 |
Resistant |
| ENSG00000272198.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.048159378 |
Resistant |
| ENSG00000272864.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.03279285 |
Resistant |
| ENSG00000273186.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.028880954 |
Resistant |
| ENSG00000204815.4 |
IPA-3 |
Brain lower grade glioma |
0.041087896 |
Resistant |
| ENSG00000205500.4 |
IPA-3 |
Brain lower grade glioma |
0.023912335 |
Resistant |
| ENSG00000214546.3 |
IPA-3 |
Brain lower grade glioma |
0.032957783 |
Resistant |
| ENSG00000223704.1 |
IPA-3 |
Brain lower grade glioma |
0.028657351 |
Resistant |
| ENSG00000223745.3 |
IPA-3 |
Brain lower grade glioma |
0.046698109 |
Resistant |
| ENSG00000224142.1 |
IPA-3 |
Brain lower grade glioma |
0.012988154 |
Resistant |
| ENSG00000224376.1 |
IPA-3 |
Brain lower grade glioma |
0.025992855 |
Resistant |
| ENSG00000225794.1 |
IPA-3 |
Brain lower grade glioma |
0.029381246 |
Resistant |
| ENSG00000225931.3 |
IPA-3 |
Brain lower grade glioma |
0.028006148 |
Resistant |
| ENSG00000225956.1 |
IPA-3 |
Brain lower grade glioma |
0.032350727 |
Resistant |
| ENSG00000226263.1 |
IPA-3 |
Brain lower grade glioma |
0.016837816 |
Resistant |
| ENSG00000226797.1 |
IPA-3 |
Brain lower grade glioma |
0.015836937 |
Resistant |
| ENSG00000228369.2 |
IPA-3 |
Brain lower grade glioma |
0.005770446 |
Resistant |
| ENSG00000228952.1 |
IPA-3 |
Brain lower grade glioma |
0.037039164 |
Resistant |
| ENSG00000229228.1 |
IPA-3 |
Brain lower grade glioma |
0.034254364 |
Resistant |
| ENSG00000231521.1 |
IPA-3 |
Brain lower grade glioma |
0.017547124 |
Resistant |
| ENSG00000233942.1 |
IPA-3 |
Brain lower grade glioma |
0.049345337 |
Resistant |
| ENSG00000233977.1 |
IPA-3 |
Brain lower grade glioma |
0.04802113 |
Resistant |
| ENSG00000233993.1 |
IPA-3 |
Brain lower grade glioma |
0.041901776 |
Resistant |
| ENSG00000234290.2 |
IPA-3 |
Brain lower grade glioma |
0.040748825 |
Resistant |
| ENSG00000234459.1 |
IPA-3 |
Brain lower grade glioma |
0.012533815 |
Resistant |
| ENSG00000234503.1 |
IPA-3 |
Brain lower grade glioma |
0.04216594 |
Resistant |
| ENSG00000234818.1 |
IPA-3 |
Brain lower grade glioma |
0.046086994 |
Resistant |
| ENSG00000236094.1 |
IPA-3 |
Brain lower grade glioma |
0.035695586 |
Resistant |
| ENSG00000236799.1 |
IPA-3 |
Brain lower grade glioma |
0.010544243 |
Resistant |
| ENSG00000236861.2 |
IPA-3 |
Brain lower grade glioma |
0.033320141 |
Resistant |
| ENSG00000236983.1 |
IPA-3 |
Brain lower grade glioma |
0.036301254 |
Resistant |
| ENSG00000240207.2 |
IPA-3 |
Brain lower grade glioma |
0.036977274 |
Resistant |
| ENSG00000240219.1 |
IPA-3 |
Brain lower grade glioma |
0.026172687 |
Resistant |
| ENSG00000240710.1 |
IPA-3 |
Brain lower grade glioma |
0.048863737 |
Resistant |
| ENSG00000241014.1 |
IPA-3 |
Brain lower grade glioma |
0.042041374 |
Resistant |
| ENSG00000243018.1 |
IPA-3 |
Brain lower grade glioma |
0.014635603 |
Resistant |
| ENSG00000243485.2 |
IPA-3 |
Brain lower grade glioma |
0.024416056 |
Resistant |
| ENSG00000244063.1 |
IPA-3 |
Brain lower grade glioma |
0.020948555 |
Resistant |
| ENSG00000244676.1 |
IPA-3 |
Brain lower grade glioma |
0.019881582 |
Resistant |
| ENSG00000245060.2 |
IPA-3 |
Brain lower grade glioma |
0.012121611 |
Resistant |
| ENSG00000246363.2 |
IPA-3 |
Brain lower grade glioma |
0.028853706 |
Resistant |
| ENSG00000246627.2 |
IPA-3 |
Brain lower grade glioma |
0.01924542 |
Resistant |
| ENSG00000248202.1 |
IPA-3 |
Brain lower grade glioma |
0.047472858 |
Resistant |
| ENSG00000248318.1 |
IPA-3 |
Brain lower grade glioma |
0.047683283 |
Resistant |
| ENSG00000248779.1 |
IPA-3 |
Brain lower grade glioma |
0.045798956 |
Resistant |
| ENSG00000250237.1 |
IPA-3 |
Brain lower grade glioma |
0.026497647 |
Resistant |
| ENSG00000253404.1 |
IPA-3 |
Brain lower grade glioma |
0.042971346 |
Resistant |
| ENSG00000253632.1 |
IPA-3 |
Brain lower grade glioma |
0.007378961 |
Resistant |
| ENSG00000254248.1 |
IPA-3 |
Brain lower grade glioma |
0.034396677 |
Resistant |
| ENSG00000254263.1 |
IPA-3 |
Brain lower grade glioma |
0.017836019 |
Resistant |
| ENSG00000254451.2 |
IPA-3 |
Brain lower grade glioma |
0.020248439 |
Resistant |
| ENSG00000254577.1 |
IPA-3 |
Brain lower grade glioma |
0.048007504 |
Resistant |
| ENSG00000254718.2 |
IPA-3 |
Brain lower grade glioma |
0.045898168 |
Resistant |
| ENSG00000254762.1 |
IPA-3 |
Brain lower grade glioma |
0.012235452 |
Resistant |
| ENSG00000254964.1 |
IPA-3 |
Brain lower grade glioma |
0.017434529 |
Resistant |
| ENSG00000255084.1 |
IPA-3 |
Brain lower grade glioma |
0.035787192 |
Resistant |
| ENSG00000255176.1 |
IPA-3 |
Brain lower grade glioma |
0.03047459 |
Resistant |
| ENSG00000256271.1 |
IPA-3 |
Brain lower grade glioma |
0.045333992 |
Resistant |
| ENSG00000256721.1 |
IPA-3 |
Brain lower grade glioma |
0.01858432 |
Resistant |
| ENSG00000257449.1 |
IPA-3 |
Brain lower grade glioma |
0.030751017 |
Resistant |
| ENSG00000258646.1 |
IPA-3 |
Brain lower grade glioma |
0.005505164 |
Resistant |
| ENSG00000259201.1 |
IPA-3 |
Brain lower grade glioma |
0.024229837 |
Resistant |
| ENSG00000259536.1 |
IPA-3 |
Brain lower grade glioma |
0.012864272 |
Resistant |
| ENSG00000260086.1 |
IPA-3 |
Brain lower grade glioma |
0.032830894 |
Resistant |
| ENSG00000260231.1 |
IPA-3 |
Brain lower grade glioma |
0.031107508 |
Resistant |
| ENSG00000260597.1 |
IPA-3 |
Brain lower grade glioma |
0.039207423 |
Resistant |
| ENSG00000260618.1 |
IPA-3 |
Brain lower grade glioma |
0.00268787 |
Resistant |
| ENSG00000260790.1 |
IPA-3 |
Brain lower grade glioma |
0.027775319 |
Resistant |
| ENSG00000261043.2 |
IPA-3 |
Brain lower grade glioma |
0.04943987 |
Resistant |
| ENSG00000261114.1 |
IPA-3 |
Brain lower grade glioma |
0.007615604 |
Resistant |
| ENSG00000261270.1 |
IPA-3 |
Brain lower grade glioma |
0.022802663 |
Resistant |
| ENSG00000261324.2 |
IPA-3 |
Brain lower grade glioma |
0.044632909 |
Resistant |
| ENSG00000261390.1 |
IPA-3 |
Brain lower grade glioma |
0.039600567 |
Resistant |
| ENSG00000261978.1 |
IPA-3 |
Brain lower grade glioma |
0.047303787 |
Resistant |
| ENSG00000262313.1 |
IPA-3 |
Brain lower grade glioma |
0.020204111 |
Resistant |
| ENSG00000262905.1 |
IPA-3 |
Brain lower grade glioma |
0.0209305 |
Resistant |
| ENSG00000263293.1 |
IPA-3 |
Brain lower grade glioma |
0.042866739 |
Resistant |
| ENSG00000263531.1 |
IPA-3 |
Brain lower grade glioma |
0.02029005 |
Resistant |
| ENSG00000263982.1 |
IPA-3 |
Brain lower grade glioma |
0.042948883 |
Resistant |
| ENSG00000264630.1 |
IPA-3 |
Brain lower grade glioma |
0.039868237 |
Resistant |
| ENSG00000264672.1 |
IPA-3 |
Brain lower grade glioma |
0.030719135 |
Resistant |
| ENSG00000266598.1 |
IPA-3 |
Brain lower grade glioma |
0.044513731 |
Resistant |
| ENSG00000267143.1 |
IPA-3 |
Brain lower grade glioma |
0.02598619 |
Resistant |
| ENSG00000267606.1 |
IPA-3 |
Brain lower grade glioma |
0.014102393 |
Resistant |
| ENSG00000267715.1 |
IPA-3 |
Brain lower grade glioma |
0.04320574 |
Resistant |
| ENSG00000268047.1 |
IPA-3 |
Brain lower grade glioma |
0.015745819 |
Resistant |
| ENSG00000268199.2 |
IPA-3 |
Brain lower grade glioma |
0.049617259 |
Resistant |
| ENSG00000268392.1 |
IPA-3 |
Brain lower grade glioma |
0.020287789 |
Resistant |
| ENSG00000268605.1 |
IPA-3 |
Brain lower grade glioma |
0.048565036 |
Resistant |
| ENSG00000268650.3 |
IPA-3 |
Brain lower grade glioma |
0.036746389 |
Resistant |
| ENSG00000268842.1 |
IPA-3 |
Brain lower grade glioma |
0.035143353 |
Resistant |
| ENSG00000269392.1 |
IPA-3 |
Brain lower grade glioma |
0.039725866 |
Resistant |
| ENSG00000269463.1 |
IPA-3 |
Brain lower grade glioma |
0.044036549 |
Resistant |
| ENSG00000270140.1 |
IPA-3 |
Brain lower grade glioma |
0.014985053 |
Resistant |
| ENSG00000270760.1 |
IPA-3 |
Brain lower grade glioma |
0.020888619 |
Resistant |
| ENSG00000271086.1 |
IPA-3 |
Brain lower grade glioma |
0.016943935 |
Resistant |
| ENSG00000271259.1 |
IPA-3 |
Brain lower grade glioma |
0.020367903 |
Resistant |
| ENSG00000271327.1 |
IPA-3 |
Brain lower grade glioma |
0.008202498 |
Resistant |
| ENSG00000272239.1 |
IPA-3 |
Brain lower grade glioma |
0.032405519 |
Resistant |
| ENSG00000272248.1 |
IPA-3 |
Brain lower grade glioma |
0.043694074 |
Resistant |
| ENSG00000272483.1 |
IPA-3 |
Brain lower grade glioma |
0.0331888 |
Resistant |
| ENSG00000272922.1 |
IPA-3 |
Brain lower grade glioma |
0.039078094 |
Resistant |
| ENSG00000272949.1 |
IPA-3 |
Brain lower grade glioma |
0.027889256 |
Resistant |
| ENSG00000273123.1 |
IPA-3 |
Brain lower grade glioma |
0.012331756 |
Resistant |
| ENSG00000213863.2 |
IPA-3 |
Lung squamous cell carcinoma |
0.003157457 |
Resistant |
| ENSG00000214546.3 |
IPA-3 |
Lung squamous cell carcinoma |
0.026532174 |
Resistant |
| ENSG00000221571.2 |
IPA-3 |
Lung squamous cell carcinoma |
0.026952611 |
Resistant |
| ENSG00000223523.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.040590253 |
Resistant |
| ENSG00000223652.2 |
IPA-3 |
Lung squamous cell carcinoma |
0.016220052 |
Resistant |
| ENSG00000223685.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.042642378 |
Resistant |
| ENSG00000223749.3 |
IPA-3 |
Lung squamous cell carcinoma |
0.039609174 |
Resistant |
| ENSG00000223882.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.040895212 |
Resistant |
| ENSG00000224050.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.022292607 |
Resistant |
| ENSG00000224272.2 |
IPA-3 |
Lung squamous cell carcinoma |
0.044770096 |
Resistant |
| ENSG00000225063.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.015805007 |
Resistant |
| ENSG00000226302.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.028270433 |
Resistant |
| ENSG00000226578.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.023314376 |
Resistant |
| ENSG00000226649.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.007317019 |
Resistant |
| ENSG00000226786.2 |
IPA-3 |
Lung squamous cell carcinoma |
0.007705619 |
Resistant |
| ENSG00000226890.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.038903266 |
Resistant |
| ENSG00000227116.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.021463073 |
Resistant |
| ENSG00000227245.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.018964137 |
Resistant |
| ENSG00000227374.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.048989907 |
Resistant |
| ENSG00000227479.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.033298048 |
Resistant |
| ENSG00000227895.4 |
IPA-3 |
Lung squamous cell carcinoma |
0.030874964 |
Resistant |
| ENSG00000229065.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.007547178 |
Resistant |
| ENSG00000229236.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.024728903 |
Resistant |
| ENSG00000230699.2 |
IPA-3 |
Lung squamous cell carcinoma |
0.017261236 |
Resistant |
| ENSG00000231863.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.046990186 |
Resistant |
| ENSG00000233080.2 |
IPA-3 |
Lung squamous cell carcinoma |
0.015072743 |
Resistant |
| ENSG00000233590.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.035576917 |
Resistant |
| ENSG00000233852.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.009919941 |
Resistant |
| ENSG00000233926.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.014820636 |
Resistant |
| ENSG00000235007.2 |
IPA-3 |
Lung squamous cell carcinoma |
0.039878833 |
Resistant |
| ENSG00000235209.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.017455049 |
Resistant |
| ENSG00000235246.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.032617206 |
Resistant |
| ENSG00000235947.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.032828191 |
Resistant |
| ENSG00000236066.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.023635942 |
Resistant |
| ENSG00000236472.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.043235474 |
Resistant |
| ENSG00000236544.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.041475151 |
Resistant |
| ENSG00000236545.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.0147618 |
Resistant |
| ENSG00000236601.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.018869012 |
Resistant |
| ENSG00000236983.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.039043581 |
Resistant |
| ENSG00000237021.2 |
IPA-3 |
Lung squamous cell carcinoma |
0.040269496 |
Resistant |
| ENSG00000237234.2 |
IPA-3 |
Lung squamous cell carcinoma |
0.043397937 |
Resistant |
| ENSG00000237281.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.023923607 |
Resistant |
| ENSG00000237587.2 |
IPA-3 |
Lung squamous cell carcinoma |
0.016489631 |
Resistant |
| ENSG00000237853.2 |
IPA-3 |
Lung squamous cell carcinoma |
0.021216749 |
Resistant |
| ENSG00000237862.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.040432401 |
Resistant |
| ENSG00000238272.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.032723215 |
Resistant |
| ENSG00000239265.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.038012971 |
Resistant |
| ENSG00000239828.2 |
IPA-3 |
Lung squamous cell carcinoma |
0.021973848 |
Resistant |
| ENSG00000240219.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.019738642 |
Resistant |
| ENSG00000240710.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.045368433 |
Resistant |
| ENSG00000241180.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.025098226 |
Resistant |
| ENSG00000241219.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.017407339 |
Resistant |
| ENSG00000242082.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.016939101 |
Resistant |
| ENSG00000245651.2 |
IPA-3 |
Lung squamous cell carcinoma |
0.038584519 |
Resistant |
| ENSG00000245667.2 |
IPA-3 |
Lung squamous cell carcinoma |
0.04659506 |
Resistant |
| ENSG00000248150.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.027457491 |
Resistant |
| ENSG00000248165.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.034951178 |
Resistant |
| ENSG00000248479.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.032683003 |
Resistant |
| ENSG00000249085.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.022727496 |
Resistant |
| ENSG00000249595.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.006110511 |
Resistant |
| ENSG00000249825.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.002844062 |
Resistant |
| ENSG00000250039.3 |
IPA-3 |
Lung squamous cell carcinoma |
0.015460853 |
Resistant |
| ENSG00000250295.2 |
IPA-3 |
Lung squamous cell carcinoma |
0.036935104 |
Resistant |
| ENSG00000250846.2 |
IPA-3 |
Lung squamous cell carcinoma |
0.0452694 |
Resistant |
| ENSG00000253112.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.01532249 |
Resistant |
| ENSG00000253184.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.0267328 |
Resistant |
| ENSG00000253618.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.043644744 |
Resistant |
| ENSG00000253819.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.037781688 |
Resistant |
| ENSG00000253878.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.038810548 |
Resistant |
| ENSG00000254353.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.006741545 |
Resistant |
| ENSG00000254592.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.003531662 |
Resistant |
| ENSG00000254839.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.025159695 |
Resistant |
| ENSG00000255343.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.038645898 |
Resistant |
| ENSG00000257202.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.038005807 |
Resistant |
| ENSG00000257298.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.017900142 |
Resistant |
| ENSG00000259200.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.010940713 |
Resistant |
| ENSG00000260171.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.01831074 |
Resistant |
| ENSG00000260197.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.021252066 |
Resistant |
| ENSG00000260706.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.031461493 |
Resistant |
| ENSG00000260816.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.026825279 |
Resistant |
| ENSG00000261040.2 |
IPA-3 |
Lung squamous cell carcinoma |
0.040478842 |
Resistant |
| ENSG00000261076.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.047893192 |
Resistant |
| ENSG00000261170.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.017862632 |
Resistant |
| ENSG00000261396.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.010851773 |
Resistant |
| ENSG00000261430.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.000663712 |
Resistant |
| ENSG00000262952.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.033747583 |
Resistant |
| ENSG00000263603.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.023193547 |
Resistant |
| ENSG00000264421.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.014366463 |
Resistant |
| ENSG00000264660.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.036785088 |
Resistant |
| ENSG00000265265.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.037155178 |
Resistant |
| ENSG00000266935.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.0342831 |
Resistant |
| ENSG00000266941.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.026735314 |
Resistant |
| ENSG00000266993.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.003289932 |
Resistant |
| ENSG00000267232.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.011224331 |
Resistant |
| ENSG00000267268.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.028482546 |
Resistant |
| ENSG00000267275.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.025846697 |
Resistant |
| ENSG00000267299.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.005611042 |
Resistant |
| ENSG00000267550.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.03606734 |
Resistant |
| ENSG00000267677.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.043660911 |
Resistant |
| ENSG00000268164.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.011244147 |
Resistant |
| ENSG00000269400.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.027971701 |
Resistant |
| ENSG00000270988.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.047561676 |
Resistant |
| ENSG00000271401.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.013753853 |
Resistant |
| ENSG00000272327.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.00994332 |
Resistant |
| ENSG00000272438.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.025327479 |
Resistant |
| ENSG00000272834.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.007851563 |
Resistant |
| ENSG00000272848.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.026439225 |
Resistant |
| ENSG00000272958.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.046980501 |
Resistant |
| ENSG00000273068.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.026323416 |
Resistant |
| ENSG00000273325.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.031395278 |
Resistant |
| ENSG00000175873.3 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.009488273 |
Resistant |
| ENSG00000180458.2 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.009265599 |
Resistant |
| ENSG00000189419.5 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.011925197 |
Resistant |
| ENSG00000203650.3 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.020077801 |
Resistant |
| ENSG00000212978.5 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.044872796 |
Resistant |
| ENSG00000223797.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.01395858 |
Resistant |
| ENSG00000224043.3 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.026669211 |
Resistant |
| ENSG00000228889.2 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.001228581 |
Resistant |
| ENSG00000231858.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.012568632 |
Resistant |
| ENSG00000233008.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.029899139 |
Resistant |
| ENSG00000233461.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.03320544 |
Resistant |
| ENSG00000235760.3 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.020196729 |
Resistant |
| ENSG00000235908.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.030349831 |
Resistant |
| ENSG00000243766.3 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.026896429 |
Resistant |
| ENSG00000245105.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.00329874 |
Resistant |
| ENSG00000247765.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.019891809 |
Resistant |
| ENSG00000249502.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.012749327 |
Resistant |
| ENSG00000249849.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.047078274 |
Resistant |
| ENSG00000253986.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.030734492 |
Resistant |
| ENSG00000254409.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.033700437 |
Resistant |
| ENSG00000255276.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.029753478 |
Resistant |
| ENSG00000257004.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.001378444 |
Resistant |
| ENSG00000257931.2 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.040738613 |
Resistant |
| ENSG00000258344.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.001524108 |
Resistant |
| ENSG00000258938.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.011429815 |
Resistant |
| ENSG00000259901.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.047448616 |
Resistant |
| ENSG00000261886.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.019419785 |
Resistant |
| ENSG00000262213.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.040146012 |
Resistant |
| ENSG00000263753.2 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.001311023 |
Resistant |
| ENSG00000264469.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.008585559 |
Resistant |
| ENSG00000265091.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.026446585 |
Resistant |
| ENSG00000265656.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.015426757 |
Resistant |
| ENSG00000266912.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.027759487 |
Resistant |
| ENSG00000267191.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.005262663 |
Resistant |
| ENSG00000267248.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.020375046 |
Resistant |
| ENSG00000267394.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.034637271 |
Resistant |
| ENSG00000267397.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.006869104 |
Resistant |
| ENSG00000267470.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.045428315 |
Resistant |
| ENSG00000268262.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.003181431 |
Resistant |
| ENSG00000268836.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.002494739 |
Resistant |
| ENSG00000269473.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.013639414 |
Resistant |
| ENSG00000270159.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.029130589 |
Resistant |
| ENSG00000272077.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.031235274 |
Resistant |
| ENSG00000272373.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.047887569 |
Resistant |
| ENSG00000272960.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.008662069 |
Resistant |
| ENSG00000273281.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.040660981 |
Resistant |
| ENSG00000188825.9 |
IPA-3 |
Pancreatic adenocarcinoma |
0.021963781 |
Resistant |
| ENSG00000203441.2 |
IPA-3 |
Pancreatic adenocarcinoma |
0.04027919 |
Resistant |
| ENSG00000204588.5 |
IPA-3 |
Pancreatic adenocarcinoma |
0.016968506 |
Resistant |
| ENSG00000205266.5 |
IPA-3 |
Pancreatic adenocarcinoma |
0.038045838 |
Resistant |
| ENSG00000226310.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.04387441 |
Resistant |
| ENSG00000226876.2 |
IPA-3 |
Pancreatic adenocarcinoma |
0.016080901 |
Resistant |
| ENSG00000227110.2 |
IPA-3 |
Pancreatic adenocarcinoma |
0.033776603 |
Resistant |
| ENSG00000227619.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.045934116 |
Resistant |
| ENSG00000227885.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.019662615 |
Resistant |
| ENSG00000228487.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.020883809 |
Resistant |
| ENSG00000231233.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.027700113 |
Resistant |
| ENSG00000231393.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.026994662 |
Resistant |
| ENSG00000231551.2 |
IPA-3 |
Pancreatic adenocarcinoma |
0.034171518 |
Resistant |
| ENSG00000231890.3 |
IPA-3 |
Pancreatic adenocarcinoma |
0.014474136 |
Resistant |
| ENSG00000232656.3 |
IPA-3 |
Pancreatic adenocarcinoma |
0.03033365 |
Resistant |
| ENSG00000233030.2 |
IPA-3 |
Pancreatic adenocarcinoma |
0.006310014 |
Resistant |
| ENSG00000233203.2 |
IPA-3 |
Pancreatic adenocarcinoma |
0.037023835 |
Resistant |
| ENSG00000235398.4 |
IPA-3 |
Pancreatic adenocarcinoma |
0.045689664 |
Resistant |
| ENSG00000235726.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.040418857 |
Resistant |
| ENSG00000236008.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.043000713 |
Resistant |
| ENSG00000236137.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.046128759 |
Resistant |
| ENSG00000236943.2 |
IPA-3 |
Pancreatic adenocarcinoma |
0.030930836 |
Resistant |
| ENSG00000237523.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.024617345 |
Resistant |
| ENSG00000237686.2 |
IPA-3 |
Pancreatic adenocarcinoma |
0.02193816 |
Resistant |
| ENSG00000240875.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.046664548 |
Resistant |
| ENSG00000245498.2 |
IPA-3 |
Pancreatic adenocarcinoma |
0.045633755 |
Resistant |
| ENSG00000245522.2 |
IPA-3 |
Pancreatic adenocarcinoma |
0.038185264 |
Resistant |
| ENSG00000247095.2 |
IPA-3 |
Pancreatic adenocarcinoma |
0.03848835 |
Resistant |
| ENSG00000248323.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.042593572 |
Resistant |
| ENSG00000248690.2 |
IPA-3 |
Pancreatic adenocarcinoma |
0.044727957 |
Resistant |
| ENSG00000249328.2 |
IPA-3 |
Pancreatic adenocarcinoma |
0.04803645 |
Resistant |
| ENSG00000250295.2 |
IPA-3 |
Pancreatic adenocarcinoma |
0.014741215 |
Resistant |
| ENSG00000251136.4 |
IPA-3 |
Pancreatic adenocarcinoma |
0.049806054 |
Resistant |
| ENSG00000253327.2 |
IPA-3 |
Pancreatic adenocarcinoma |
0.042997629 |
Resistant |
| ENSG00000253636.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.045620451 |
Resistant |
| ENSG00000254837.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.016762255 |
Resistant |
| ENSG00000256802.2 |
IPA-3 |
Pancreatic adenocarcinoma |
0.018516084 |
Resistant |
| ENSG00000258479.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.041776328 |
Resistant |
| ENSG00000258658.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.036047484 |
Resistant |
| ENSG00000258891.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.012466727 |
Resistant |
| ENSG00000259298.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.011453724 |
Resistant |
| ENSG00000259553.2 |
IPA-3 |
Pancreatic adenocarcinoma |
0.047487291 |
Resistant |
| ENSG00000259668.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.030298221 |
Resistant |
| ENSG00000259673.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.043507789 |
Resistant |
| ENSG00000259783.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.009167465 |
Resistant |
| ENSG00000260608.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.028086256 |
Resistant |
| ENSG00000261068.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.024202557 |
Resistant |
| ENSG00000261437.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.044005214 |
Resistant |
| ENSG00000262172.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.043022028 |
Resistant |
| ENSG00000262319.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.036557182 |
Resistant |
| ENSG00000263214.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.023624028 |
Resistant |
| ENSG00000263325.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.045650761 |
Resistant |
| ENSG00000263893.2 |
IPA-3 |
Pancreatic adenocarcinoma |
0.042629509 |
Resistant |
| ENSG00000265490.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.032960588 |
Resistant |
| ENSG00000265778.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.042383488 |
Resistant |
| ENSG00000266718.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.031690325 |
Resistant |
| ENSG00000267394.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.012447194 |
Resistant |
| ENSG00000268518.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.022261874 |
Resistant |
| ENSG00000271366.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.007895751 |
Resistant |
| ENSG00000271762.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.037535936 |
Resistant |
| ENSG00000272689.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.047689066 |
Resistant |
| ENSG00000272761.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.04987612 |
Resistant |
| ENSG00000273174.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.045442097 |
Resistant |
| ENSG00000273237.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.037751909 |
Resistant |
| ENSG00000273443.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.003781175 |
Resistant |
| ENSG00000273472.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.014043902 |
Resistant |
| ENSG00000223821.1 |
IPA-3 |
Sarcoma |
0.013879289 |
Resistant |
| ENSG00000224738.1 |
IPA-3 |
Sarcoma |
0.019403331 |
Resistant |
| ENSG00000228393.3 |
IPA-3 |
Sarcoma |
0.041129372 |
Resistant |
| ENSG00000232876.1 |
IPA-3 |
Sarcoma |
0.024394072 |
Resistant |
| ENSG00000233694.1 |
IPA-3 |
Sarcoma |
0.024073062 |
Resistant |
| ENSG00000237950.1 |
IPA-3 |
Sarcoma |
0.038230913 |
Resistant |
| ENSG00000245651.2 |
IPA-3 |
Sarcoma |
0.000606809 |
Resistant |
| ENSG00000255520.1 |
IPA-3 |
Sarcoma |
0.000510624 |
Resistant |
| ENSG00000256124.1 |
IPA-3 |
Sarcoma |
0.029911189 |
Resistant |
| ENSG00000257004.1 |
IPA-3 |
Sarcoma |
0.042118581 |
Resistant |
| ENSG00000258813.1 |
IPA-3 |
Sarcoma |
0.023194068 |
Resistant |
| ENSG00000259462.1 |
IPA-3 |
Sarcoma |
0.014591024 |
Resistant |
| ENSG00000259590.1 |
IPA-3 |
Sarcoma |
0.048055639 |
Resistant |
| ENSG00000260037.1 |
IPA-3 |
Sarcoma |
0.034727165 |
Resistant |
| ENSG00000260317.1 |
IPA-3 |
Sarcoma |
0.037606832 |
Resistant |
| ENSG00000260369.2 |
IPA-3 |
Sarcoma |
0.025538162 |
Resistant |
| ENSG00000260545.1 |
IPA-3 |
Sarcoma |
0.031309311 |
Resistant |
| ENSG00000261366.1 |
IPA-3 |
Sarcoma |
0.029067086 |
Resistant |
| ENSG00000261697.1 |
IPA-3 |
Sarcoma |
0.032839177 |
Resistant |
| ENSG00000267432.1 |
IPA-3 |
Sarcoma |
0.014249807 |
Resistant |
| ENSG00000271200.1 |
IPA-3 |
Sarcoma |
0.04179974 |
Resistant |
| ENSG00000271871.1 |
IPA-3 |
Sarcoma |
0.036681908 |
Resistant |
| ENSG00000272004.1 |
IPA-3 |
Sarcoma |
0.044707758 |
Resistant |
| ENSG00000272192.1 |
IPA-3 |
Sarcoma |
0.035269247 |
Resistant |
| ENSG00000179219.5 |
IPA-3 |
Skin cutaneous melanoma |
0.023485535 |
Resistant |
| ENSG00000189196.4 |
IPA-3 |
Skin cutaneous melanoma |
0.010319968 |
Resistant |
| ENSG00000213994.3 |
IPA-3 |
Skin cutaneous melanoma |
0.037964379 |
Resistant |
| ENSG00000223714.1 |
IPA-3 |
Skin cutaneous melanoma |
0.048789817 |
Resistant |
| ENSG00000223759.2 |
IPA-3 |
Skin cutaneous melanoma |
0.035506459 |
Resistant |
| ENSG00000223804.1 |
IPA-3 |
Skin cutaneous melanoma |
0.019561888 |
Resistant |
| ENSG00000226179.1 |
IPA-3 |
Skin cutaneous melanoma |
0.034451737 |
Resistant |
| ENSG00000226367.1 |
IPA-3 |
Skin cutaneous melanoma |
0.010405982 |
Resistant |
| ENSG00000226386.1 |
IPA-3 |
Skin cutaneous melanoma |
0.028941347 |
Resistant |
| ENSG00000227959.1 |
IPA-3 |
Skin cutaneous melanoma |
0.044741824 |
Resistant |
| ENSG00000228649.4 |
IPA-3 |
Skin cutaneous melanoma |
0.027872145 |
Resistant |
| ENSG00000231599.1 |
IPA-3 |
Skin cutaneous melanoma |
0.042919857 |
Resistant |
| ENSG00000232874.1 |
IPA-3 |
Skin cutaneous melanoma |
0.037715119 |
Resistant |
| ENSG00000233215.1 |
IPA-3 |
Skin cutaneous melanoma |
0.037271974 |
Resistant |
| ENSG00000233368.2 |
IPA-3 |
Skin cutaneous melanoma |
0.035269761 |
Resistant |
| ENSG00000233547.1 |
IPA-3 |
Skin cutaneous melanoma |
0.026913469 |
Resistant |
| ENSG00000234432.3 |
IPA-3 |
Skin cutaneous melanoma |
0.017650563 |
Resistant |
| ENSG00000235159.1 |
IPA-3 |
Skin cutaneous melanoma |
0.042635825 |
Resistant |
| ENSG00000235398.4 |
IPA-3 |
Skin cutaneous melanoma |
0.04978016 |
Resistant |
| ENSG00000235999.1 |
IPA-3 |
Skin cutaneous melanoma |
0.025090619 |
Resistant |
| ENSG00000236318.1 |
IPA-3 |
Skin cutaneous melanoma |
0.046839142 |
Resistant |
| ENSG00000236383.3 |
IPA-3 |
Skin cutaneous melanoma |
0.024794154 |
Resistant |
| ENSG00000236943.2 |
IPA-3 |
Skin cutaneous melanoma |
0.043934142 |
Resistant |
| ENSG00000237857.2 |
IPA-3 |
Skin cutaneous melanoma |
0.037328418 |
Resistant |
| ENSG00000237886.1 |
IPA-3 |
Skin cutaneous melanoma |
0.046309715 |
Resistant |
| ENSG00000241211.1 |
IPA-3 |
Skin cutaneous melanoma |
0.008785602 |
Resistant |
| ENSG00000242767.1 |
IPA-3 |
Skin cutaneous melanoma |
0.03024994 |
Resistant |
| ENSG00000244513.2 |
IPA-3 |
Skin cutaneous melanoma |
0.041558928 |
Resistant |
| ENSG00000245105.1 |
IPA-3 |
Skin cutaneous melanoma |
0.007857865 |
Resistant |
| ENSG00000249526.1 |
IPA-3 |
Skin cutaneous melanoma |
0.036338408 |
Resistant |
| ENSG00000249899.1 |
IPA-3 |
Skin cutaneous melanoma |
0.02541931 |
Resistant |
| ENSG00000255434.1 |
IPA-3 |
Skin cutaneous melanoma |
0.039662282 |
Resistant |
| ENSG00000255723.1 |
IPA-3 |
Skin cutaneous melanoma |
0.036477899 |
Resistant |
| ENSG00000258821.1 |
IPA-3 |
Skin cutaneous melanoma |
0.037329276 |
Resistant |
| ENSG00000259002.1 |
IPA-3 |
Skin cutaneous melanoma |
0.04340422 |
Resistant |
| ENSG00000259644.1 |
IPA-3 |
Skin cutaneous melanoma |
0.032606338 |
Resistant |
| ENSG00000260206.1 |
IPA-3 |
Skin cutaneous melanoma |
0.02379193 |
Resistant |
| ENSG00000260328.1 |
IPA-3 |
Skin cutaneous melanoma |
0.025329633 |
Resistant |
| ENSG00000260585.1 |
IPA-3 |
Skin cutaneous melanoma |
0.017047589 |
Resistant |
| ENSG00000260793.2 |
IPA-3 |
Skin cutaneous melanoma |
0.005104851 |
Resistant |
| ENSG00000261168.1 |
IPA-3 |
Skin cutaneous melanoma |
0.005198883 |
Resistant |
| ENSG00000261207.1 |
IPA-3 |
Skin cutaneous melanoma |
0.039634602 |
Resistant |
| ENSG00000261211.1 |
IPA-3 |
Skin cutaneous melanoma |
0.01737371 |
Resistant |
| ENSG00000261242.1 |
IPA-3 |
Skin cutaneous melanoma |
0.029317872 |
Resistant |
| ENSG00000266261.1 |
IPA-3 |
Skin cutaneous melanoma |
0.029465502 |
Resistant |
| ENSG00000267246.1 |
IPA-3 |
Skin cutaneous melanoma |
0.037184871 |
Resistant |
| ENSG00000267342.1 |
IPA-3 |
Skin cutaneous melanoma |
0.045925992 |
Resistant |
| ENSG00000268947.1 |
IPA-3 |
Skin cutaneous melanoma |
0.027592669 |
Resistant |
| ENSG00000269423.1 |
IPA-3 |
Skin cutaneous melanoma |
0.041018053 |
Resistant |
| ENSG00000270755.1 |
IPA-3 |
Skin cutaneous melanoma |
0.007238306 |
Resistant |
| ENSG00000272003.1 |
IPA-3 |
Skin cutaneous melanoma |
0.042289663 |
Resistant |
| ENSG00000272544.1 |
IPA-3 |
Skin cutaneous melanoma |
0.048644153 |
Resistant |
| ENSG00000272646.1 |
IPA-3 |
Skin cutaneous melanoma |
0.043055215 |
Resistant |
| ENSG00000272746.1 |
IPA-3 |
Skin cutaneous melanoma |
0.032589259 |
Resistant |
| ENSG00000272788.1 |
IPA-3 |
Skin cutaneous melanoma |
0.010933132 |
Resistant |
| ENSG00000273018.1 |
IPA-3 |
Skin cutaneous melanoma |
0.029731615 |
Resistant |
| ENSG00000273038.1 |
IPA-3 |
Skin cutaneous melanoma |
0.022962709 |
Resistant |
| ENSG00000273160.1 |
IPA-3 |
Skin cutaneous melanoma |
0.008869311 |
Resistant |
| ENSG00000273416.1 |
IPA-3 |
Skin cutaneous melanoma |
0.015947955 |
Resistant |
| ENSG00000182648.7 |
IPA-3 |
Thyroid carcinoma |
0.001543764 |
Resistant |
| ENSG00000184324.11 |
IPA-3 |
Thyroid carcinoma |
0.033968472 |
Resistant |
| ENSG00000197463.8 |
IPA-3 |
Thyroid carcinoma |
0.022095022 |
Resistant |
| ENSG00000204929.7 |
IPA-3 |
Thyroid carcinoma |
0.007549045 |
Resistant |
| ENSG00000204934.6 |
IPA-3 |
Thyroid carcinoma |
0.041406711 |
Resistant |
| ENSG00000205181.5 |
IPA-3 |
Thyroid carcinoma |
0.032534906 |
Resistant |
| ENSG00000214548.10 |
IPA-3 |
Thyroid carcinoma |
0.012999213 |
Resistant |
| ENSG00000223799.1 |
IPA-3 |
Thyroid carcinoma |
0.011335896 |
Resistant |
| ENSG00000224023.6 |
IPA-3 |
Thyroid carcinoma |
0.034222061 |
Resistant |
| ENSG00000225302.1 |
IPA-3 |
Thyroid carcinoma |
0.010559685 |
Resistant |
| ENSG00000226310.1 |
IPA-3 |
Thyroid carcinoma |
0.028463212 |
Resistant |
| ENSG00000228021.3 |
IPA-3 |
Thyroid carcinoma |
0.000975556 |
Resistant |
| ENSG00000228223.1 |
IPA-3 |
Thyroid carcinoma |
0.045577092 |
Resistant |
| ENSG00000228412.2 |
IPA-3 |
Thyroid carcinoma |
0.031083519 |
Resistant |
| ENSG00000228686.2 |
IPA-3 |
Thyroid carcinoma |
0.033712775 |
Resistant |
| ENSG00000232224.1 |
IPA-3 |
Thyroid carcinoma |
0.026019029 |
Resistant |
| ENSG00000232694.2 |
IPA-3 |
Thyroid carcinoma |
0.042323852 |
Resistant |
| ENSG00000235560.3 |
IPA-3 |
Thyroid carcinoma |
0.039628234 |
Resistant |
| ENSG00000236209.1 |
IPA-3 |
Thyroid carcinoma |
0.034488541 |
Resistant |
| ENSG00000237149.4 |
IPA-3 |
Thyroid carcinoma |
0.01480557 |
Resistant |
| ENSG00000240449.1 |
IPA-3 |
Thyroid carcinoma |
0.026722779 |
Resistant |
| ENSG00000244041.3 |
IPA-3 |
Thyroid carcinoma |
0.018041572 |
Resistant |
| ENSG00000255568.2 |
IPA-3 |
Thyroid carcinoma |
0.013516622 |
Resistant |
| ENSG00000257139.1 |
IPA-3 |
Thyroid carcinoma |
0.019399663 |
Resistant |
| ENSG00000257563.1 |
IPA-3 |
Thyroid carcinoma |
0.02715909 |
Resistant |
| ENSG00000259319.1 |
IPA-3 |
Thyroid carcinoma |
0.040110101 |
Resistant |
| ENSG00000259884.1 |
IPA-3 |
Thyroid carcinoma |
0.008955006 |
Resistant |
| ENSG00000260793.2 |
IPA-3 |
Thyroid carcinoma |
0.004847802 |
Resistant |
| ENSG00000261420.1 |
IPA-3 |
Thyroid carcinoma |
0.015433316 |
Resistant |
| ENSG00000261770.1 |
IPA-3 |
Thyroid carcinoma |
0.048001582 |
Resistant |
| ENSG00000262468.1 |
IPA-3 |
Thyroid carcinoma |
0.014270777 |
Resistant |
| ENSG00000262873.1 |
IPA-3 |
Thyroid carcinoma |
0.03344766 |
Resistant |
| ENSG00000263050.1 |
IPA-3 |
Thyroid carcinoma |
0.04565792 |
Resistant |
| ENSG00000265206.2 |
IPA-3 |
Thyroid carcinoma |
0.022545668 |
Resistant |
| ENSG00000265519.1 |
IPA-3 |
Thyroid carcinoma |
0.002796973 |
Resistant |
| ENSG00000267470.1 |
IPA-3 |
Thyroid carcinoma |
0.008600852 |
Resistant |
| ENSG00000267493.2 |
IPA-3 |
Thyroid carcinoma |
0.016187502 |
Resistant |
| ENSG00000267730.1 |
IPA-3 |
Thyroid carcinoma |
0.03651859 |
Resistant |
| ENSG00000267750.1 |
IPA-3 |
Thyroid carcinoma |
0.002414008 |
Resistant |
| ENSG00000269843.1 |
IPA-3 |
Thyroid carcinoma |
0.019914792 |
Resistant |
| ENSG00000270068.1 |
IPA-3 |
Thyroid carcinoma |
0.000584216 |
Resistant |
| ENSG00000271265.1 |
IPA-3 |
Thyroid carcinoma |
0.032712932 |
Resistant |
| ENSG00000272065.1 |
IPA-3 |
Thyroid carcinoma |
0.004859821 |
Resistant |
| ENSG00000272172.1 |
IPA-3 |
Thyroid carcinoma |
0.020892358 |
Resistant |
| ENSG00000272828.1 |
IPA-3 |
Thyroid carcinoma |
0.007053982 |
Resistant |
| ENSG00000273139.1 |
IPA-3 |
Thyroid carcinoma |
0.030298422 |
Resistant |
| ENSG00000273162.1 |
IPA-3 |
Thyroid carcinoma |
0.020335715 |
Resistant |
| ENSG00000177822.3 |
IPA-3 |
Bladder urothelial carcinoma |
0.048048003 |
Sensitive |
| ENSG00000224822.1 |
IPA-3 |
Bladder urothelial carcinoma |
0.000233734 |
Sensitive |
| ENSG00000229672.2 |
IPA-3 |
Bladder urothelial carcinoma |
0.02252327 |
Sensitive |
| ENSG00000230310.1 |
IPA-3 |
Bladder urothelial carcinoma |
0.049996888 |
Sensitive |
| ENSG00000233496.1 |
IPA-3 |
Bladder urothelial carcinoma |
0.028312629 |
Sensitive |
| ENSG00000233800.2 |
IPA-3 |
Bladder urothelial carcinoma |
0.000127673 |
Sensitive |
| ENSG00000236153.1 |
IPA-3 |
Bladder urothelial carcinoma |
0.042572808 |
Sensitive |
| ENSG00000249234.1 |
IPA-3 |
Bladder urothelial carcinoma |
0.002720171 |
Sensitive |
| ENSG00000253284.2 |
IPA-3 |
Bladder urothelial carcinoma |
0.032397462 |
Sensitive |
| ENSG00000259182.1 |
IPA-3 |
Bladder urothelial carcinoma |
0.029783399 |
Sensitive |
| ENSG00000260084.1 |
IPA-3 |
Bladder urothelial carcinoma |
0.015228851 |
Sensitive |
| ENSG00000263874.1 |
IPA-3 |
Bladder urothelial carcinoma |
0.045999207 |
Sensitive |
| ENSG00000268895.1 |
IPA-3 |
Bladder urothelial carcinoma |
0.048591605 |
Sensitive |
| ENSG00000273492.1 |
IPA-3 |
Bladder urothelial carcinoma |
0.005963972 |
Sensitive |
| ENSG00000118412.8 |
IPA-3 |
Breast invasive carcinoma |
0.037862275 |
Sensitive |
| ENSG00000178977.3 |
IPA-3 |
Breast invasive carcinoma |
0.027599514 |
Sensitive |
| ENSG00000214773.1 |
IPA-3 |
Breast invasive carcinoma |
0.001775533 |
Sensitive |
| ENSG00000226330.1 |
IPA-3 |
Breast invasive carcinoma |
0.045608584 |
Sensitive |
| ENSG00000226416.1 |
IPA-3 |
Breast invasive carcinoma |
0.047034977 |
Sensitive |
| ENSG00000228784.3 |
IPA-3 |
Breast invasive carcinoma |
0.037001438 |
Sensitive |
| ENSG00000229109.1 |
IPA-3 |
Breast invasive carcinoma |
0.04931677 |
Sensitive |
| ENSG00000230454.1 |
IPA-3 |
Breast invasive carcinoma |
0.043395665 |
Sensitive |
| ENSG00000231170.1 |
IPA-3 |
Breast invasive carcinoma |
0.033637975 |
Sensitive |
| ENSG00000231533.1 |
IPA-3 |
Breast invasive carcinoma |
0.037880952 |
Sensitive |
| ENSG00000231811.2 |
IPA-3 |
Breast invasive carcinoma |
0.048373004 |
Sensitive |
| ENSG00000232593.2 |
IPA-3 |
Breast invasive carcinoma |
0.011150321 |
Sensitive |
| ENSG00000234019.1 |
IPA-3 |
Breast invasive carcinoma |
0.040178473 |
Sensitive |
| ENSG00000235029.1 |
IPA-3 |
Breast invasive carcinoma |
0.030986106 |
Sensitive |
| ENSG00000235530.2 |
IPA-3 |
Breast invasive carcinoma |
0.041292141 |
Sensitive |
| ENSG00000239377.1 |
IPA-3 |
Breast invasive carcinoma |
0.015869505 |
Sensitive |
| ENSG00000246451.2 |
IPA-3 |
Breast invasive carcinoma |
0.039024027 |
Sensitive |
| ENSG00000247373.2 |
IPA-3 |
Breast invasive carcinoma |
0.027504412 |
Sensitive |
| ENSG00000249417.1 |
IPA-3 |
Breast invasive carcinoma |
0.01585845 |
Sensitive |
| ENSG00000251034.1 |
IPA-3 |
Breast invasive carcinoma |
0.038632212 |
Sensitive |
| ENSG00000254340.1 |
IPA-3 |
Breast invasive carcinoma |
0.048748351 |
Sensitive |
| ENSG00000254528.3 |
IPA-3 |
Breast invasive carcinoma |
0.014710421 |
Sensitive |
| ENSG00000255857.1 |
IPA-3 |
Breast invasive carcinoma |
0.022093041 |
Sensitive |
| ENSG00000257534.1 |
IPA-3 |
Breast invasive carcinoma |
0.008747796 |
Sensitive |
| ENSG00000258561.1 |
IPA-3 |
Breast invasive carcinoma |
0.004995311 |
Sensitive |
| ENSG00000258730.1 |
IPA-3 |
Breast invasive carcinoma |
0.047445196 |
Sensitive |
| ENSG00000259103.1 |
IPA-3 |
Breast invasive carcinoma |
0.037664519 |
Sensitive |
| ENSG00000260233.2 |
IPA-3 |
Breast invasive carcinoma |
0.047080051 |
Sensitive |
| ENSG00000260545.1 |
IPA-3 |
Breast invasive carcinoma |
0.037223688 |
Sensitive |
| ENSG00000260796.1 |
IPA-3 |
Breast invasive carcinoma |
0.036146494 |
Sensitive |
| ENSG00000260955.2 |
IPA-3 |
Breast invasive carcinoma |
0.034363489 |
Sensitive |
| ENSG00000261043.2 |
IPA-3 |
Breast invasive carcinoma |
0.038136025 |
Sensitive |
| ENSG00000266176.1 |
IPA-3 |
Breast invasive carcinoma |
0.041679397 |
Sensitive |
| ENSG00000266371.1 |
IPA-3 |
Breast invasive carcinoma |
0.046758634 |
Sensitive |
| ENSG00000267009.2 |
IPA-3 |
Breast invasive carcinoma |
0.023199003 |
Sensitive |
| ENSG00000269976.1 |
IPA-3 |
Breast invasive carcinoma |
0.039688627 |
Sensitive |
| ENSG00000270130.1 |
IPA-3 |
Breast invasive carcinoma |
0.019160226 |
Sensitive |
| ENSG00000271993.1 |
IPA-3 |
Breast invasive carcinoma |
0.034283907 |
Sensitive |
| ENSG00000273447.1 |
IPA-3 |
Breast invasive carcinoma |
0.04850824 |
Sensitive |
| ENSG00000149656.4 |
IPA-3 |
Colon adenocarcinoma |
0.045866282 |
Sensitive |
| ENSG00000185495.6 |
IPA-3 |
Colon adenocarcinoma |
0.035934714 |
Sensitive |
| ENSG00000196421.3 |
IPA-3 |
Colon adenocarcinoma |
0.003045116 |
Sensitive |
| ENSG00000204623.4 |
IPA-3 |
Colon adenocarcinoma |
0.023273655 |
Sensitive |
| ENSG00000224934.2 |
IPA-3 |
Colon adenocarcinoma |
0.004294909 |
Sensitive |
| ENSG00000225075.1 |
IPA-3 |
Colon adenocarcinoma |
0.029352647 |
Sensitive |
| ENSG00000225177.1 |
IPA-3 |
Colon adenocarcinoma |
0.031452225 |
Sensitive |
| ENSG00000225278.3 |
IPA-3 |
Colon adenocarcinoma |
0.021885624 |
Sensitive |
| ENSG00000226310.1 |
IPA-3 |
Colon adenocarcinoma |
0.033773624 |
Sensitive |
| ENSG00000226312.3 |
IPA-3 |
Colon adenocarcinoma |
0.031793763 |
Sensitive |
| ENSG00000227006.1 |
IPA-3 |
Colon adenocarcinoma |
0.027829785 |
Sensitive |
| ENSG00000227741.1 |
IPA-3 |
Colon adenocarcinoma |
0.030414766 |
Sensitive |
| ENSG00000228022.1 |
IPA-3 |
Colon adenocarcinoma |
0.042935527 |
Sensitive |
| ENSG00000228630.1 |
IPA-3 |
Colon adenocarcinoma |
0.003443974 |
Sensitive |
| ENSG00000229118.1 |
IPA-3 |
Colon adenocarcinoma |
0.020208486 |
Sensitive |
| ENSG00000229167.1 |
IPA-3 |
Colon adenocarcinoma |
0.006969405 |
Sensitive |
| ENSG00000230262.2 |
IPA-3 |
Colon adenocarcinoma |
0.03122748 |
Sensitive |
| ENSG00000231290.1 |
IPA-3 |
Colon adenocarcinoma |
0.009117671 |
Sensitive |
| ENSG00000231840.1 |
IPA-3 |
Colon adenocarcinoma |
0.002332344 |
Sensitive |
| ENSG00000231920.1 |
IPA-3 |
Colon adenocarcinoma |
0.002411729 |
Sensitive |
| ENSG00000232116.2 |
IPA-3 |
Colon adenocarcinoma |
0.0162064 |
Sensitive |
| ENSG00000232229.1 |
IPA-3 |
Colon adenocarcinoma |
0.039678451 |
Sensitive |
| ENSG00000232406.2 |
IPA-3 |
Colon adenocarcinoma |
0.022452377 |
Sensitive |
| ENSG00000233101.6 |
IPA-3 |
Colon adenocarcinoma |
0.026844593 |
Sensitive |
| ENSG00000234252.1 |
IPA-3 |
Colon adenocarcinoma |
0.041565191 |
Sensitive |
| ENSG00000234350.1 |
IPA-3 |
Colon adenocarcinoma |
0.02690318 |
Sensitive |
| ENSG00000235313.1 |
IPA-3 |
Colon adenocarcinoma |
0.041584613 |
Sensitive |
| ENSG00000236641.1 |
IPA-3 |
Colon adenocarcinoma |
0.037753936 |
Sensitive |
| ENSG00000236991.2 |
IPA-3 |
Colon adenocarcinoma |
0.042080736 |
Sensitive |
| ENSG00000237399.3 |
IPA-3 |
Colon adenocarcinoma |
0.043720173 |
Sensitive |
| ENSG00000238198.1 |
IPA-3 |
Colon adenocarcinoma |
0.01352077 |
Sensitive |
| ENSG00000240875.1 |
IPA-3 |
Colon adenocarcinoma |
0.045394755 |
Sensitive |
| ENSG00000244124.1 |
IPA-3 |
Colon adenocarcinoma |
0.022697374 |
Sensitive |
| ENSG00000244327.1 |
IPA-3 |
Colon adenocarcinoma |
0.014005515 |
Sensitive |
| ENSG00000245532.4 |
IPA-3 |
Colon adenocarcinoma |
0.028845398 |
Sensitive |
| ENSG00000246451.2 |
IPA-3 |
Colon adenocarcinoma |
0.009248635 |
Sensitive |
| ENSG00000246982.2 |
IPA-3 |
Colon adenocarcinoma |
0.012551322 |
Sensitive |
| ENSG00000247381.2 |
IPA-3 |
Colon adenocarcinoma |
0.024871132 |
Sensitive |
| ENSG00000247679.2 |
IPA-3 |
Colon adenocarcinoma |
0.040473719 |
Sensitive |
| ENSG00000249196.2 |
IPA-3 |
Colon adenocarcinoma |
0.04666576 |
Sensitive |
| ENSG00000249379.1 |
IPA-3 |
Colon adenocarcinoma |
0.026307718 |
Sensitive |
| ENSG00000249593.2 |
IPA-3 |
Colon adenocarcinoma |
0.043704606 |
Sensitive |
| ENSG00000250748.2 |
IPA-3 |
Colon adenocarcinoma |
0.034845046 |
Sensitive |
| ENSG00000250764.1 |
IPA-3 |
Colon adenocarcinoma |
0.032901428 |
Sensitive |
| ENSG00000251666.1 |
IPA-3 |
Colon adenocarcinoma |
0.033365901 |
Sensitive |
| ENSG00000253552.3 |
IPA-3 |
Colon adenocarcinoma |
0.018579073 |
Sensitive |
| ENSG00000254363.2 |
IPA-3 |
Colon adenocarcinoma |
0.0325243 |
Sensitive |
| ENSG00000254369.2 |
IPA-3 |
Colon adenocarcinoma |
0.023788702 |
Sensitive |
| ENSG00000254461.1 |
IPA-3 |
Colon adenocarcinoma |
0.020889169 |
Sensitive |
| ENSG00000255306.1 |
IPA-3 |
Colon adenocarcinoma |
0.033467151 |
Sensitive |
| ENSG00000255970.1 |
IPA-3 |
Colon adenocarcinoma |
0.039176617 |
Sensitive |
| ENSG00000257488.1 |
IPA-3 |
Colon adenocarcinoma |
0.02365762 |
Sensitive |
| ENSG00000257596.1 |
IPA-3 |
Colon adenocarcinoma |
0.021541002 |
Sensitive |
| ENSG00000258334.1 |
IPA-3 |
Colon adenocarcinoma |
0.012981295 |
Sensitive |
| ENSG00000259448.2 |
IPA-3 |
Colon adenocarcinoma |
0.029453648 |
Sensitive |
| ENSG00000259456.2 |
IPA-3 |
Colon adenocarcinoma |
0.045044522 |
Sensitive |
| ENSG00000260277.1 |
IPA-3 |
Colon adenocarcinoma |
0.011646662 |
Sensitive |
| ENSG00000260495.1 |
IPA-3 |
Colon adenocarcinoma |
0.048225834 |
Sensitive |
| ENSG00000260597.1 |
IPA-3 |
Colon adenocarcinoma |
0.033905358 |
Sensitive |
| ENSG00000260671.1 |
IPA-3 |
Colon adenocarcinoma |
0.027744449 |
Sensitive |
| ENSG00000261094.2 |
IPA-3 |
Colon adenocarcinoma |
0.038569804 |
Sensitive |
| ENSG00000261353.1 |
IPA-3 |
Colon adenocarcinoma |
0.021716199 |
Sensitive |
| ENSG00000262362.1 |
IPA-3 |
Colon adenocarcinoma |
0.020368765 |
Sensitive |
| ENSG00000263182.1 |
IPA-3 |
Colon adenocarcinoma |
0.048817468 |
Sensitive |
| ENSG00000263975.1 |
IPA-3 |
Colon adenocarcinoma |
0.040404967 |
Sensitive |
| ENSG00000265474.1 |
IPA-3 |
Colon adenocarcinoma |
0.046212139 |
Sensitive |
| ENSG00000266236.1 |
IPA-3 |
Colon adenocarcinoma |
0.011449076 |
Sensitive |
| ENSG00000266644.1 |
IPA-3 |
Colon adenocarcinoma |
0.004379242 |
Sensitive |
| ENSG00000267141.1 |
IPA-3 |
Colon adenocarcinoma |
0.038464 |
Sensitive |
| ENSG00000267759.1 |
IPA-3 |
Colon adenocarcinoma |
0.018405617 |
Sensitive |
| ENSG00000267834.1 |
IPA-3 |
Colon adenocarcinoma |
0.039368519 |
Sensitive |
| ENSG00000268499.1 |
IPA-3 |
Colon adenocarcinoma |
0.012884448 |
Sensitive |
| ENSG00000268518.1 |
IPA-3 |
Colon adenocarcinoma |
0.034147123 |
Sensitive |
| ENSG00000268520.1 |
IPA-3 |
Colon adenocarcinoma |
0.02340315 |
Sensitive |
| ENSG00000269082.1 |
IPA-3 |
Colon adenocarcinoma |
0.01789249 |
Sensitive |
| ENSG00000269925.1 |
IPA-3 |
Colon adenocarcinoma |
0.025385405 |
Sensitive |
| ENSG00000269929.1 |
IPA-3 |
Colon adenocarcinoma |
0.022274089 |
Sensitive |
| ENSG00000270108.1 |
IPA-3 |
Colon adenocarcinoma |
0.006176925 |
Sensitive |
| ENSG00000270133.1 |
IPA-3 |
Colon adenocarcinoma |
0.043763703 |
Sensitive |
| ENSG00000271327.1 |
IPA-3 |
Colon adenocarcinoma |
0.028185359 |
Sensitive |
| ENSG00000271833.1 |
IPA-3 |
Colon adenocarcinoma |
0.028565097 |
Sensitive |
| ENSG00000272374.1 |
IPA-3 |
Colon adenocarcinoma |
0.02613233 |
Sensitive |
| ENSG00000272505.1 |
IPA-3 |
Colon adenocarcinoma |
0.011292034 |
Sensitive |
| ENSG00000272630.1 |
IPA-3 |
Colon adenocarcinoma |
0.029979711 |
Sensitive |
| ENSG00000272645.1 |
IPA-3 |
Colon adenocarcinoma |
0.031008752 |
Sensitive |
| ENSG00000272792.1 |
IPA-3 |
Colon adenocarcinoma |
0.042913038 |
Sensitive |
| ENSG00000272954.1 |
IPA-3 |
Colon adenocarcinoma |
0.033249174 |
Sensitive |
| ENSG00000273002.1 |
IPA-3 |
Colon adenocarcinoma |
0.023977582 |
Sensitive |
| ENSG00000273230.1 |
IPA-3 |
Colon adenocarcinoma |
0.031710016 |
Sensitive |
| ENSG00000236423.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.028160786 |
Sensitive |
| ENSG00000249395.2 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.015288318 |
Sensitive |
| ENSG00000267016.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.046307976 |
Sensitive |
| ENSG00000268544.1 |
IPA-3 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.01974529 |
Sensitive |
| ENSG00000228802.1 |
IPA-3 |
Esophageal cancer |
0.029368447 |
Sensitive |
| ENSG00000267560.1 |
IPA-3 |
Esophageal cancer |
0.048734395 |
Sensitive |
| ENSG00000206113.3 |
IPA-3 |
Head and neck squamous cell carcinoma |
0.032293884 |
Sensitive |
| ENSG00000214546.3 |
IPA-3 |
Head and neck squamous cell carcinoma |
0.03733491 |
Sensitive |
| ENSG00000223759.2 |
IPA-3 |
Head and neck squamous cell carcinoma |
0.0263993 |
Sensitive |
| ENSG00000224079.1 |
IPA-3 |
Head and neck squamous cell carcinoma |
0.03863761 |
Sensitive |
| ENSG00000227512.1 |
IPA-3 |
Head and neck squamous cell carcinoma |
0.02488135 |
Sensitive |
| ENSG00000231908.1 |
IPA-3 |
Head and neck squamous cell carcinoma |
0.033630575 |
Sensitive |
| ENSG00000232636.2 |
IPA-3 |
Head and neck squamous cell carcinoma |
0.017410878 |
Sensitive |
| ENSG00000234091.1 |
IPA-3 |
Head and neck squamous cell carcinoma |
0.024131441 |
Sensitive |
| ENSG00000234459.1 |
IPA-3 |
Head and neck squamous cell carcinoma |
0.009103425 |
Sensitive |
| ENSG00000234705.1 |
IPA-3 |
Head and neck squamous cell carcinoma |
0.009794293 |
Sensitive |
| ENSG00000236908.2 |
IPA-3 |
Head and neck squamous cell carcinoma |
0.030407799 |
Sensitive |
| ENSG00000237152.2 |
IPA-3 |
Head and neck squamous cell carcinoma |
0.041416894 |
Sensitive |
| ENSG00000241180.1 |
IPA-3 |
Head and neck squamous cell carcinoma |
0.031283232 |
Sensitive |
| ENSG00000244625.1 |
IPA-3 |
Head and neck squamous cell carcinoma |
0.032890221 |
Sensitive |
| ENSG00000248677.1 |
IPA-3 |
Head and neck squamous cell carcinoma |
0.005675607 |
Sensitive |
| ENSG00000254419.1 |
IPA-3 |
Head and neck squamous cell carcinoma |
0.010369818 |
Sensitive |
| ENSG00000254879.1 |
IPA-3 |
Head and neck squamous cell carcinoma |
0.024397831 |
Sensitive |
| ENSG00000255247.1 |
IPA-3 |
Head and neck squamous cell carcinoma |
0.042844872 |
Sensitive |
| ENSG00000256712.1 |
IPA-3 |
Head and neck squamous cell carcinoma |
0.032166155 |
Sensitive |
| ENSG00000256894.1 |
IPA-3 |
Head and neck squamous cell carcinoma |
0.016893602 |
Sensitive |
| ENSG00000257027.1 |
IPA-3 |
Head and neck squamous cell carcinoma |
0.037405082 |
Sensitive |
| ENSG00000257925.1 |
IPA-3 |
Head and neck squamous cell carcinoma |
0.022740157 |
Sensitive |
| ENSG00000259687.1 |
IPA-3 |
Head and neck squamous cell carcinoma |
0.041392543 |
Sensitive |
| ENSG00000259701.1 |
IPA-3 |
Head and neck squamous cell carcinoma |
0.030796798 |
Sensitive |
| ENSG00000260787.1 |
IPA-3 |
Head and neck squamous cell carcinoma |
0.019384979 |
Sensitive |
| ENSG00000260833.2 |
IPA-3 |
Head and neck squamous cell carcinoma |
0.018790521 |
Sensitive |
| ENSG00000261455.1 |
IPA-3 |
Head and neck squamous cell carcinoma |
0.04267506 |
Sensitive |
| ENSG00000270562.1 |
IPA-3 |
Head and neck squamous cell carcinoma |
0.026367576 |
Sensitive |
| ENSG00000272512.1 |
IPA-3 |
Head and neck squamous cell carcinoma |
0.027438283 |
Sensitive |
| ENSG00000273143.1 |
IPA-3 |
Head and neck squamous cell carcinoma |
0.025488148 |
Sensitive |
| ENSG00000273445.1 |
IPA-3 |
Head and neck squamous cell carcinoma |
0.030041418 |
Sensitive |
| ENSG00000100181.17 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.022155205 |
Sensitive |
| ENSG00000177640.11 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.033766444 |
Sensitive |
| ENSG00000179743.2 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.003777408 |
Sensitive |
| ENSG00000185203.7 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.02458031 |
Sensitive |
| ENSG00000203288.3 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.043230314 |
Sensitive |
| ENSG00000203645.2 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.035639351 |
Sensitive |
| ENSG00000204706.10 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.049409386 |
Sensitive |
| ENSG00000213468.3 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.033054358 |
Sensitive |
| ENSG00000214770.2 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.02859404 |
Sensitive |
| ENSG00000223571.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.029841513 |
Sensitive |
| ENSG00000223635.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.044095578 |
Sensitive |
| ENSG00000223774.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.022427316 |
Sensitive |
| ENSG00000224020.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.009412212 |
Sensitive |
| ENSG00000224142.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.006239233 |
Sensitive |
| ENSG00000224905.2 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.014029575 |
Sensitive |
| ENSG00000225077.2 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.010003761 |
Sensitive |
| ENSG00000225218.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.039008277 |
Sensitive |
| ENSG00000225528.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.029319344 |
Sensitive |
| ENSG00000225986.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.03451945 |
Sensitive |
| ENSG00000226245.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.028928107 |
Sensitive |
| ENSG00000226684.2 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.025292142 |
Sensitive |
| ENSG00000227006.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.043693182 |
Sensitive |
| ENSG00000227374.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.032655009 |
Sensitive |
| ENSG00000227637.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.010461368 |
Sensitive |
| ENSG00000228288.2 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.009499937 |
Sensitive |
| ENSG00000229065.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.028095167 |
Sensitive |
| ENSG00000229525.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.015174782 |
Sensitive |
| ENSG00000229536.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.036859823 |
Sensitive |
| ENSG00000229654.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.016966672 |
Sensitive |
| ENSG00000229750.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.041993821 |
Sensitive |
| ENSG00000229776.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.006055758 |
Sensitive |
| ENSG00000229952.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.020237376 |
Sensitive |
| ENSG00000229989.3 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.015478593 |
Sensitive |
| ENSG00000230140.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.045007064 |
Sensitive |
| ENSG00000230773.2 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.033561489 |
Sensitive |
| ENSG00000231187.2 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.049450719 |
Sensitive |
| ENSG00000231193.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.003583742 |
Sensitive |
| ENSG00000231327.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.000678994 |
Sensitive |
| ENSG00000231393.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.037743144 |
Sensitive |
| ENSG00000231439.3 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.01855251 |
Sensitive |
| ENSG00000231769.2 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.0464377 |
Sensitive |
| ENSG00000231851.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.027568265 |
Sensitive |
| ENSG00000232021.2 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.009114001 |
Sensitive |
| ENSG00000232412.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.048068428 |
Sensitive |
| ENSG00000232470.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.037618339 |
Sensitive |
| ENSG00000232611.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.020509056 |
Sensitive |
| ENSG00000232656.3 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.002952979 |
Sensitive |
| ENSG00000232876.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.022063959 |
Sensitive |
| ENSG00000233056.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.030241821 |
Sensitive |
| ENSG00000233396.3 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.032250512 |
Sensitive |
| ENSG00000233483.2 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.047385073 |
Sensitive |
| ENSG00000233593.2 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.010919456 |
Sensitive |
| ENSG00000234028.3 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.046887929 |
Sensitive |
| ENSG00000234129.3 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.030045863 |
Sensitive |
| ENSG00000234134.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.031235408 |
Sensitive |
| ENSG00000234230.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.025885337 |
Sensitive |
| ENSG00000234245.2 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.013193057 |
Sensitive |
| ENSG00000234277.2 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.003042727 |
Sensitive |
| ENSG00000234509.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.034239123 |
Sensitive |
| ENSG00000234630.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.0284678 |
Sensitive |
| ENSG00000234663.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.037399288 |
Sensitive |
| ENSG00000234817.2 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.027558709 |
Sensitive |
| ENSG00000235172.3 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.019009592 |
Sensitive |
| ENSG00000235545.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.025205156 |
Sensitive |
| ENSG00000235903.3 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.004523477 |
Sensitive |
| ENSG00000236703.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.022979093 |
Sensitive |
| ENSG00000236947.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.029188726 |
Sensitive |
| ENSG00000237594.2 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.008899934 |
Sensitive |
| ENSG00000237689.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.008242759 |
Sensitive |
| ENSG00000237718.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.011311367 |
Sensitive |
| ENSG00000237883.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.029211414 |
Sensitive |
| ENSG00000237945.3 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.00214496 |
Sensitive |
| ENSG00000237976.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.025896966 |
Sensitive |
| ENSG00000240915.2 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.046556866 |
Sensitive |
| ENSG00000243533.2 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.030279664 |
Sensitive |
| ENSG00000246174.3 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.001003802 |
Sensitive |
| ENSG00000246339.4 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.019598392 |
Sensitive |
| ENSG00000247675.2 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.040545829 |
Sensitive |
| ENSG00000247934.3 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.039853946 |
Sensitive |
| ENSG00000247970.2 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.006708083 |
Sensitive |
| ENSG00000248668.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.002705781 |
Sensitive |
| ENSG00000248774.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.037654447 |
Sensitive |
| ENSG00000249421.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.017656444 |
Sensitive |
| ENSG00000249492.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.02601156 |
Sensitive |
| ENSG00000249494.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.027579848 |
Sensitive |
| ENSG00000249637.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.001923965 |
Sensitive |
| ENSG00000249650.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.008928287 |
Sensitive |
| ENSG00000249684.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.007593683 |
Sensitive |
| ENSG00000249894.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.045458815 |
Sensitive |
| ENSG00000249898.3 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.015702481 |
Sensitive |
| ENSG00000250260.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.001353638 |
Sensitive |
| ENSG00000250802.2 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.029160585 |
Sensitive |
| ENSG00000251298.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.017022193 |
Sensitive |
| ENSG00000251323.2 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.001359456 |
Sensitive |
| ENSG00000251387.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.043613165 |
Sensitive |
| ENSG00000251867.2 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.014676568 |
Sensitive |
| ENSG00000253433.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.019967928 |
Sensitive |
| ENSG00000253744.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.007025973 |
Sensitive |
| ENSG00000254340.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.02641461 |
Sensitive |
| ENSG00000254592.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.02166562 |
Sensitive |
| ENSG00000254682.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.020606617 |
Sensitive |
| ENSG00000254691.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.000730159 |
Sensitive |
| ENSG00000257084.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.008415922 |
Sensitive |
| ENSG00000257497.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.009729196 |
Sensitive |
| ENSG00000257698.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.003671677 |
Sensitive |
| ENSG00000258534.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.043330204 |
Sensitive |
| ENSG00000259135.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.036902529 |
Sensitive |
| ENSG00000259201.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.037106242 |
Sensitive |
| ENSG00000259416.2 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.037884129 |
Sensitive |
| ENSG00000259488.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.039548532 |
Sensitive |
| ENSG00000259499.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.005168609 |
Sensitive |
| ENSG00000259804.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.045219262 |
Sensitive |
| ENSG00000260017.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.037925589 |
Sensitive |
| ENSG00000260206.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.006819807 |
Sensitive |
| ENSG00000260231.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.003277904 |
Sensitive |
| ENSG00000260278.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.016500871 |
Sensitive |
| ENSG00000260329.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.021977406 |
Sensitive |
| ENSG00000260351.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.028317774 |
Sensitive |
| ENSG00000260423.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.022227942 |
Sensitive |
| ENSG00000260579.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.033286554 |
Sensitive |
| ENSG00000260589.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.010824757 |
Sensitive |
| ENSG00000260626.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.001682558 |
Sensitive |
| ENSG00000260973.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.016635904 |
Sensitive |
| ENSG00000260986.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.021248207 |
Sensitive |
| ENSG00000260992.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.043784868 |
Sensitive |
| ENSG00000261043.2 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.024461909 |
Sensitive |
| ENSG00000261135.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.002004177 |
Sensitive |
| ENSG00000261168.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.033087265 |
Sensitive |
| ENSG00000261326.2 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.014551988 |
Sensitive |
| ENSG00000261390.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.027494409 |
Sensitive |
| ENSG00000261404.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.021140821 |
Sensitive |
| ENSG00000261431.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.015038968 |
Sensitive |
| ENSG00000261441.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.029122238 |
Sensitive |
| ENSG00000261610.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.005732701 |
Sensitive |
| ENSG00000261754.2 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.033433703 |
Sensitive |
| ENSG00000261758.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.008727068 |
Sensitive |
| ENSG00000261886.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.016971469 |
Sensitive |
| ENSG00000263338.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.035899432 |
Sensitive |
| ENSG00000263612.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.018245208 |
Sensitive |
| ENSG00000264885.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.011584958 |
Sensitive |
| ENSG00000265334.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.025201919 |
Sensitive |
| ENSG00000266290.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.031944577 |
Sensitive |
| ENSG00000266538.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.002679426 |
Sensitive |
| ENSG00000266936.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.003125143 |
Sensitive |
| ENSG00000266969.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.024059293 |
Sensitive |
| ENSG00000267136.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.040739634 |
Sensitive |
| ENSG00000267347.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.042934387 |
Sensitive |
| ENSG00000267568.2 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.039606471 |
Sensitive |
| ENSG00000267651.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.046699747 |
Sensitive |
| ENSG00000267767.2 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.026466668 |
Sensitive |
| ENSG00000268201.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.015090681 |
Sensitive |
| ENSG00000268340.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.016476865 |
Sensitive |
| ENSG00000268536.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.026931048 |
Sensitive |
| ENSG00000268751.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.044253048 |
Sensitive |
| ENSG00000269086.2 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.012411216 |
Sensitive |
| ENSG00000269246.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.023279536 |
Sensitive |
| ENSG00000269656.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.049624346 |
Sensitive |
| ENSG00000270040.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.007763307 |
Sensitive |
| ENSG00000270482.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.0380301 |
Sensitive |
| ENSG00000270523.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.022468901 |
Sensitive |
| ENSG00000270557.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.040749066 |
Sensitive |
| ENSG00000270828.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.018798228 |
Sensitive |
| ENSG00000271109.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.022310351 |
Sensitive |
| ENSG00000271314.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.042291445 |
Sensitive |
| ENSG00000271367.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.005442819 |
Sensitive |
| ENSG00000271738.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.026556565 |
Sensitive |
| ENSG00000271757.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.012219668 |
Sensitive |
| ENSG00000271788.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.015758107 |
Sensitive |
| ENSG00000271869.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.012146881 |
Sensitive |
| ENSG00000271963.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.013534045 |
Sensitive |
| ENSG00000272023.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.030629317 |
Sensitive |
| ENSG00000272130.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.049999317 |
Sensitive |
| ENSG00000272181.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.021031371 |
Sensitive |
| ENSG00000272216.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.010752717 |
Sensitive |
| ENSG00000272301.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.004130482 |
Sensitive |
| ENSG00000272320.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.015218713 |
Sensitive |
| ENSG00000272373.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.017232028 |
Sensitive |
| ENSG00000272416.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.011248598 |
Sensitive |
| ENSG00000272426.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.006247334 |
Sensitive |
| ENSG00000272524.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.003812319 |
Sensitive |
| ENSG00000272525.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.027389505 |
Sensitive |
| ENSG00000272562.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.016459102 |
Sensitive |
| ENSG00000272716.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.007747182 |
Sensitive |
| ENSG00000272744.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.039872992 |
Sensitive |
| ENSG00000272746.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.029556395 |
Sensitive |
| ENSG00000272788.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.006224806 |
Sensitive |
| ENSG00000272791.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.00658979 |
Sensitive |
| ENSG00000272795.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.009835003 |
Sensitive |
| ENSG00000272798.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.032045818 |
Sensitive |
| ENSG00000272870.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.00486508 |
Sensitive |
| ENSG00000272927.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.042425091 |
Sensitive |
| ENSG00000272942.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.006976006 |
Sensitive |
| ENSG00000272995.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.01515183 |
Sensitive |
| ENSG00000273001.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.042799885 |
Sensitive |
| ENSG00000273015.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.024735543 |
Sensitive |
| ENSG00000273059.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.02296028 |
Sensitive |
| ENSG00000273091.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.001676389 |
Sensitive |
| ENSG00000273175.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.02738996 |
Sensitive |
| ENSG00000273216.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.043948967 |
Sensitive |
| ENSG00000273232.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.038525711 |
Sensitive |
| ENSG00000273355.1 |
IPA-3 |
Chronic Lymphocytic Leukemia |
0.036097411 |
Sensitive |
| ENSG00000174171.4 |
IPA-3 |
Brain lower grade glioma |
0.044660125 |
Sensitive |
| ENSG00000225313.2 |
IPA-3 |
Brain lower grade glioma |
0.0226143 |
Sensitive |
| ENSG00000226835.1 |
IPA-3 |
Brain lower grade glioma |
0.021532949 |
Sensitive |
| ENSG00000227279.1 |
IPA-3 |
Brain lower grade glioma |
0.047592615 |
Sensitive |
| ENSG00000228124.1 |
IPA-3 |
Brain lower grade glioma |
0.039332323 |
Sensitive |
| ENSG00000228649.4 |
IPA-3 |
Brain lower grade glioma |
0.035095904 |
Sensitive |
| ENSG00000229124.2 |
IPA-3 |
Brain lower grade glioma |
0.029499377 |
Sensitive |
| ENSG00000231992.1 |
IPA-3 |
Brain lower grade glioma |
0.01544578 |
Sensitive |
| ENSG00000232396.2 |
IPA-3 |
Brain lower grade glioma |
0.034061674 |
Sensitive |
| ENSG00000233117.2 |
IPA-3 |
Brain lower grade glioma |
0.038043991 |
Sensitive |
| ENSG00000233237.2 |
IPA-3 |
Brain lower grade glioma |
0.040485437 |
Sensitive |
| ENSG00000233532.1 |
IPA-3 |
Brain lower grade glioma |
0.040727713 |
Sensitive |
| ENSG00000234945.3 |
IPA-3 |
Brain lower grade glioma |
0.011873248 |
Sensitive |
| ENSG00000235410.1 |
IPA-3 |
Brain lower grade glioma |
0.023915177 |
Sensitive |
| ENSG00000236703.1 |
IPA-3 |
Brain lower grade glioma |
0.047060046 |
Sensitive |
| ENSG00000244310.1 |
IPA-3 |
Brain lower grade glioma |
0.033052638 |
Sensitive |
| ENSG00000257167.2 |
IPA-3 |
Brain lower grade glioma |
0.023310197 |
Sensitive |
| ENSG00000259450.1 |
IPA-3 |
Brain lower grade glioma |
0.015488263 |
Sensitive |
| ENSG00000259617.1 |
IPA-3 |
Brain lower grade glioma |
0.048446306 |
Sensitive |
| ENSG00000260378.1 |
IPA-3 |
Brain lower grade glioma |
0.048099148 |
Sensitive |
| ENSG00000266718.1 |
IPA-3 |
Brain lower grade glioma |
0.014615653 |
Sensitive |
| ENSG00000266999.1 |
IPA-3 |
Brain lower grade glioma |
0.031648492 |
Sensitive |
| ENSG00000267047.1 |
IPA-3 |
Brain lower grade glioma |
0.036005292 |
Sensitive |
| ENSG00000271781.1 |
IPA-3 |
Brain lower grade glioma |
0.006989388 |
Sensitive |
| ENSG00000271926.1 |
IPA-3 |
Brain lower grade glioma |
0.037117887 |
Sensitive |
| ENSG00000272574.1 |
IPA-3 |
Brain lower grade glioma |
0.041063323 |
Sensitive |
| ENSG00000273264.1 |
IPA-3 |
Brain lower grade glioma |
0.029957777 |
Sensitive |
| ENSG00000188825.9 |
IPA-3 |
Lung squamous cell carcinoma |
0.037735065 |
Sensitive |
| ENSG00000223462.2 |
IPA-3 |
Lung squamous cell carcinoma |
0.013853937 |
Sensitive |
| ENSG00000225649.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.016994928 |
Sensitive |
| ENSG00000225815.2 |
IPA-3 |
Lung squamous cell carcinoma |
0.046183641 |
Sensitive |
| ENSG00000227053.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.022400267 |
Sensitive |
| ENSG00000228701.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.048874863 |
Sensitive |
| ENSG00000229563.2 |
IPA-3 |
Lung squamous cell carcinoma |
0.033043838 |
Sensitive |
| ENSG00000230140.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.048001965 |
Sensitive |
| ENSG00000231291.3 |
IPA-3 |
Lung squamous cell carcinoma |
0.023536639 |
Sensitive |
| ENSG00000232034.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.049142315 |
Sensitive |
| ENSG00000232721.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.023874503 |
Sensitive |
| ENSG00000233532.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.028878158 |
Sensitive |
| ENSG00000234070.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.017212151 |
Sensitive |
| ENSG00000235398.4 |
IPA-3 |
Lung squamous cell carcinoma |
0.01492711 |
Sensitive |
| ENSG00000236230.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.010421924 |
Sensitive |
| ENSG00000236936.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.013356736 |
Sensitive |
| ENSG00000236943.2 |
IPA-3 |
Lung squamous cell carcinoma |
0.007064176 |
Sensitive |
| ENSG00000237253.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.020679 |
Sensitive |
| ENSG00000237520.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.019433779 |
Sensitive |
| ENSG00000238005.2 |
IPA-3 |
Lung squamous cell carcinoma |
0.030030035 |
Sensitive |
| ENSG00000243008.2 |
IPA-3 |
Lung squamous cell carcinoma |
0.031737565 |
Sensitive |
| ENSG00000246523.3 |
IPA-3 |
Lung squamous cell carcinoma |
0.036125336 |
Sensitive |
| ENSG00000248215.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.043808266 |
Sensitive |
| ENSG00000248740.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.034052648 |
Sensitive |
| ENSG00000248973.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.025513478 |
Sensitive |
| ENSG00000249061.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.029212527 |
Sensitive |
| ENSG00000249803.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.031956059 |
Sensitive |
| ENSG00000250284.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.02791788 |
Sensitive |
| ENSG00000250508.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.019823911 |
Sensitive |
| ENSG00000250600.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.036774727 |
Sensitive |
| ENSG00000251075.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.026631303 |
Sensitive |
| ENSG00000253111.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.049546606 |
Sensitive |
| ENSG00000253335.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.03837255 |
Sensitive |
| ENSG00000253395.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.02039619 |
Sensitive |
| ENSG00000253445.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.046168486 |
Sensitive |
| ENSG00000254458.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.013264671 |
Sensitive |
| ENSG00000254733.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.030082862 |
Sensitive |
| ENSG00000255002.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.021117717 |
Sensitive |
| ENSG00000256124.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.036233042 |
Sensitive |
| ENSG00000256582.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.038234219 |
Sensitive |
| ENSG00000257027.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.024565003 |
Sensitive |
| ENSG00000258400.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.030220882 |
Sensitive |
| ENSG00000258534.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.025630506 |
Sensitive |
| ENSG00000258914.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.027094734 |
Sensitive |
| ENSG00000258929.2 |
IPA-3 |
Lung squamous cell carcinoma |
0.021108365 |
Sensitive |
| ENSG00000260066.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.048677635 |
Sensitive |
| ENSG00000260328.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.026103012 |
Sensitive |
| ENSG00000260515.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.037059633 |
Sensitive |
| ENSG00000260744.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.004350726 |
Sensitive |
| ENSG00000264015.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.043911854 |
Sensitive |
| ENSG00000267285.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.036512302 |
Sensitive |
| ENSG00000270346.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.00999926 |
Sensitive |
| ENSG00000271998.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.037923542 |
Sensitive |
| ENSG00000272426.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.04770231 |
Sensitive |
| ENSG00000272917.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.005853085 |
Sensitive |
| ENSG00000273065.1 |
IPA-3 |
Lung squamous cell carcinoma |
0.02019398 |
Sensitive |
| ENSG00000171889.3 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.021577453 |
Sensitive |
| ENSG00000223356.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.008941933 |
Sensitive |
| ENSG00000224409.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.016702211 |
Sensitive |
| ENSG00000224843.2 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.004897939 |
Sensitive |
| ENSG00000224977.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.008257138 |
Sensitive |
| ENSG00000226386.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.018374778 |
Sensitive |
| ENSG00000226786.2 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.011428194 |
Sensitive |
| ENSG00000227116.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.049900779 |
Sensitive |
| ENSG00000227877.2 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.036344956 |
Sensitive |
| ENSG00000229672.2 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.005927115 |
Sensitive |
| ENSG00000231324.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.004558081 |
Sensitive |
| ENSG00000231507.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.001445144 |
Sensitive |
| ENSG00000231574.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.041428474 |
Sensitive |
| ENSG00000231720.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.02671986 |
Sensitive |
| ENSG00000231969.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.031508169 |
Sensitive |
| ENSG00000232110.3 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.00191703 |
Sensitive |
| ENSG00000233143.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.045253779 |
Sensitive |
| ENSG00000234283.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.033168233 |
Sensitive |
| ENSG00000234393.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.025157198 |
Sensitive |
| ENSG00000234478.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.046903564 |
Sensitive |
| ENSG00000234707.2 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.03362755 |
Sensitive |
| ENSG00000235052.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.019412035 |
Sensitive |
| ENSG00000235398.4 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.013693167 |
Sensitive |
| ENSG00000237499.2 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.044373055 |
Sensitive |
| ENSG00000237852.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.043395557 |
Sensitive |
| ENSG00000238290.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.000481884 |
Sensitive |
| ENSG00000240990.5 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.023557736 |
Sensitive |
| ENSG00000244041.3 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.038822236 |
Sensitive |
| ENSG00000245059.2 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.042087463 |
Sensitive |
| ENSG00000249550.2 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.041001075 |
Sensitive |
| ENSG00000253948.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.024499802 |
Sensitive |
| ENSG00000255395.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.00544348 |
Sensitive |
| ENSG00000255414.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.049218728 |
Sensitive |
| ENSG00000255478.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.01439983 |
Sensitive |
| ENSG00000258048.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.028233797 |
Sensitive |
| ENSG00000258345.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.022593035 |
Sensitive |
| ENSG00000259410.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.04405224 |
Sensitive |
| ENSG00000260650.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.009189777 |
Sensitive |
| ENSG00000261596.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.0139952 |
Sensitive |
| ENSG00000262380.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.033020522 |
Sensitive |
| ENSG00000268189.2 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.032904243 |
Sensitive |
| ENSG00000272158.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.018355873 |
Sensitive |
| ENSG00000272459.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.042049206 |
Sensitive |
| ENSG00000273424.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.042249107 |
Sensitive |
| ENSG00000273471.1 |
IPA-3 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.020682422 |
Sensitive |
| ENSG00000157306.10 |
IPA-3 |
Pancreatic adenocarcinoma |
0.015078078 |
Sensitive |
| ENSG00000175701.6 |
IPA-3 |
Pancreatic adenocarcinoma |
0.005357169 |
Sensitive |
| ENSG00000177738.3 |
IPA-3 |
Pancreatic adenocarcinoma |
0.004079634 |
Sensitive |
| ENSG00000178803.6 |
IPA-3 |
Pancreatic adenocarcinoma |
0.001777971 |
Sensitive |
| ENSG00000205559.3 |
IPA-3 |
Pancreatic adenocarcinoma |
0.029634752 |
Sensitive |
| ENSG00000215023.2 |
IPA-3 |
Pancreatic adenocarcinoma |
0.006286145 |
Sensitive |
| ENSG00000222035.2 |
IPA-3 |
Pancreatic adenocarcinoma |
0.014167682 |
Sensitive |
| ENSG00000224157.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.018604363 |
Sensitive |
| ENSG00000224805.2 |
IPA-3 |
Pancreatic adenocarcinoma |
0.012536561 |
Sensitive |
| ENSG00000224863.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.018841612 |
Sensitive |
| ENSG00000225675.2 |
IPA-3 |
Pancreatic adenocarcinoma |
0.001674491 |
Sensitive |
| ENSG00000226053.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.001241503 |
Sensitive |
| ENSG00000226900.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.001309204 |
Sensitive |
| ENSG00000227256.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.004229319 |
Sensitive |
| ENSG00000227482.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.033249949 |
Sensitive |
| ENSG00000227484.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.030605786 |
Sensitive |
| ENSG00000227702.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.040903013 |
Sensitive |
| ENSG00000227811.2 |
IPA-3 |
Pancreatic adenocarcinoma |
0.000206541 |
Sensitive |
| ENSG00000228044.2 |
IPA-3 |
Pancreatic adenocarcinoma |
0.000747576 |
Sensitive |
| ENSG00000228838.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.02470867 |
Sensitive |
| ENSG00000229081.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.0000364 |
Sensitive |
| ENSG00000229896.2 |
IPA-3 |
Pancreatic adenocarcinoma |
0.026549085 |
Sensitive |
| ENSG00000229950.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.0000773 |
Sensitive |
| ENSG00000230074.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.000000193 |
Sensitive |
| ENSG00000230257.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.029725597 |
Sensitive |
| ENSG00000230368.2 |
IPA-3 |
Pancreatic adenocarcinoma |
0.037300932 |
Sensitive |
| ENSG00000231636.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.006767691 |
Sensitive |
| ENSG00000231704.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.042475078 |
Sensitive |
| ENSG00000233016.2 |
IPA-3 |
Pancreatic adenocarcinoma |
0.000149453 |
Sensitive |
| ENSG00000233611.3 |
IPA-3 |
Pancreatic adenocarcinoma |
0.011625555 |
Sensitive |
| ENSG00000234222.2 |
IPA-3 |
Pancreatic adenocarcinoma |
0.000777579 |
Sensitive |
| ENSG00000234741.3 |
IPA-3 |
Pancreatic adenocarcinoma |
0.013882296 |
Sensitive |
| ENSG00000234997.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.001748676 |
Sensitive |
| ENSG00000235609.4 |
IPA-3 |
Pancreatic adenocarcinoma |
0.048923723 |
Sensitive |
| ENSG00000237738.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.000958064 |
Sensitive |
| ENSG00000237886.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.009701949 |
Sensitive |
| ENSG00000241211.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.013004638 |
Sensitive |
| ENSG00000243368.2 |
IPA-3 |
Pancreatic adenocarcinoma |
0.006687341 |
Sensitive |
| ENSG00000244998.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.017778566 |
Sensitive |
| ENSG00000247675.2 |
IPA-3 |
Pancreatic adenocarcinoma |
0.032171552 |
Sensitive |
| ENSG00000248367.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.030799742 |
Sensitive |
| ENSG00000248544.2 |
IPA-3 |
Pancreatic adenocarcinoma |
0.0000103 |
Sensitive |
| ENSG00000248758.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.015983881 |
Sensitive |
| ENSG00000250222.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.005746323 |
Sensitive |
| ENSG00000250820.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.011408139 |
Sensitive |
| ENSG00000254223.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.048268433 |
Sensitive |
| ENSG00000254353.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.003991333 |
Sensitive |
| ENSG00000254756.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.040980741 |
Sensitive |
| ENSG00000254910.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.024337072 |
Sensitive |
| ENSG00000254911.2 |
IPA-3 |
Pancreatic adenocarcinoma |
0.047276168 |
Sensitive |
| ENSG00000255443.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.013191498 |
Sensitive |
| ENSG00000256433.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.012095895 |
Sensitive |
| ENSG00000256540.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.00202552 |
Sensitive |
| ENSG00000257698.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.042112191 |
Sensitive |
| ENSG00000257809.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.034146609 |
Sensitive |
| ENSG00000258704.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.010775217 |
Sensitive |
| ENSG00000259062.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.049552868 |
Sensitive |
| ENSG00000259818.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.014981216 |
Sensitive |
| ENSG00000260081.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.022030069 |
Sensitive |
| ENSG00000260166.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.00000684 |
Sensitive |
| ENSG00000260285.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.0441272 |
Sensitive |
| ENSG00000260439.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.000944693 |
Sensitive |
| ENSG00000260778.2 |
IPA-3 |
Pancreatic adenocarcinoma |
0.005400247 |
Sensitive |
| ENSG00000260927.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.031026032 |
Sensitive |
| ENSG00000261534.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.013252972 |
Sensitive |
| ENSG00000261697.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.000557575 |
Sensitive |
| ENSG00000261744.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.026921945 |
Sensitive |
| ENSG00000262313.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.002329728 |
Sensitive |
| ENSG00000262410.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.042217922 |
Sensitive |
| ENSG00000262951.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.03141662 |
Sensitive |
| ENSG00000264365.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.00251988 |
Sensitive |
| ENSG00000264808.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.013712608 |
Sensitive |
| ENSG00000264812.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.026550402 |
Sensitive |
| ENSG00000265094.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.034392896 |
Sensitive |
| ENSG00000265494.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.022879107 |
Sensitive |
| ENSG00000266402.2 |
IPA-3 |
Pancreatic adenocarcinoma |
0.006427287 |
Sensitive |
| ENSG00000267093.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.003908707 |
Sensitive |
| ENSG00000267304.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.009518171 |
Sensitive |
| ENSG00000267405.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.026588278 |
Sensitive |
| ENSG00000267479.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.000741047 |
Sensitive |
| ENSG00000267568.2 |
IPA-3 |
Pancreatic adenocarcinoma |
0.00235715 |
Sensitive |
| ENSG00000268015.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.049632997 |
Sensitive |
| ENSG00000268049.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.021905564 |
Sensitive |
| ENSG00000268157.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.015785119 |
Sensitive |
| ENSG00000268516.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.02192774 |
Sensitive |
| ENSG00000269321.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.032531488 |
Sensitive |
| ENSG00000269696.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.007569939 |
Sensitive |
| ENSG00000269867.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.028110289 |
Sensitive |
| ENSG00000269942.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.003624991 |
Sensitive |
| ENSG00000269958.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.001271566 |
Sensitive |
| ENSG00000270041.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.03924529 |
Sensitive |
| ENSG00000270137.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.009149898 |
Sensitive |
| ENSG00000270933.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.005003298 |
Sensitive |
| ENSG00000272024.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.021672211 |
Sensitive |
| ENSG00000272192.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.002748978 |
Sensitive |
| ENSG00000272375.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.004736903 |
Sensitive |
| ENSG00000272524.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.00654773 |
Sensitive |
| ENSG00000272788.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.016075871 |
Sensitive |
| ENSG00000272810.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.034513754 |
Sensitive |
| ENSG00000273402.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.027422857 |
Sensitive |
| ENSG00000273449.1 |
IPA-3 |
Pancreatic adenocarcinoma |
0.02545806 |
Sensitive |
| ENSG00000187904.3 |
IPA-3 |
Sarcoma |
0.025041417 |
Sensitive |
| ENSG00000196960.3 |
IPA-3 |
Sarcoma |
0.031881448 |
Sensitive |
| ENSG00000227719.1 |
IPA-3 |
Sarcoma |
0.047609358 |
Sensitive |
| ENSG00000228060.1 |
IPA-3 |
Sarcoma |
0.000425637 |
Sensitive |
| ENSG00000231312.2 |
IPA-3 |
Sarcoma |
0.038116698 |
Sensitive |
| ENSG00000231429.2 |
IPA-3 |
Sarcoma |
0.033898936 |
Sensitive |
| ENSG00000231441.1 |
IPA-3 |
Sarcoma |
0.046095118 |
Sensitive |
| ENSG00000232295.3 |
IPA-3 |
Sarcoma |
0.035754386 |
Sensitive |
| ENSG00000233776.1 |
IPA-3 |
Sarcoma |
0.044203626 |
Sensitive |
| ENSG00000235802.1 |
IPA-3 |
Sarcoma |
0.006654937 |
Sensitive |
| ENSG00000236390.1 |
IPA-3 |
Sarcoma |
0.016483133 |
Sensitive |
| ENSG00000243055.1 |
IPA-3 |
Sarcoma |
0.044802666 |
Sensitive |
| ENSG00000253837.1 |
IPA-3 |
Sarcoma |
0.018833333 |
Sensitive |
| ENSG00000257999.1 |
IPA-3 |
Sarcoma |
0.044094848 |
Sensitive |
| ENSG00000258620.1 |
IPA-3 |
Sarcoma |
0.021165064 |
Sensitive |
| ENSG00000261101.1 |
IPA-3 |
Sarcoma |
0.048001175 |
Sensitive |
| ENSG00000262678.1 |
IPA-3 |
Sarcoma |
0.000772692 |
Sensitive |
| ENSG00000266805.1 |
IPA-3 |
Sarcoma |
0.016828433 |
Sensitive |
| ENSG00000270102.1 |
IPA-3 |
Sarcoma |
0.02953147 |
Sensitive |
| ENSG00000272033.1 |
IPA-3 |
Sarcoma |
0.039008162 |
Sensitive |
| ENSG00000272799.1 |
IPA-3 |
Sarcoma |
0.031746264 |
Sensitive |
| ENSG00000223571.1 |
IPA-3 |
Skin cutaneous melanoma |
0.042423585 |
Sensitive |
| ENSG00000223838.1 |
IPA-3 |
Skin cutaneous melanoma |
0.028659998 |
Sensitive |
| ENSG00000224329.2 |
IPA-3 |
Skin cutaneous melanoma |
0.02498846 |
Sensitive |
| ENSG00000224638.1 |
IPA-3 |
Skin cutaneous melanoma |
0.037994077 |
Sensitive |
| ENSG00000226009.1 |
IPA-3 |
Skin cutaneous melanoma |
0.043716316 |
Sensitive |
| ENSG00000226816.2 |
IPA-3 |
Skin cutaneous melanoma |
0.001163672 |
Sensitive |
| ENSG00000228548.1 |
IPA-3 |
Skin cutaneous melanoma |
0.009000697 |
Sensitive |
| ENSG00000230184.1 |
IPA-3 |
Skin cutaneous melanoma |
0.041703221 |
Sensitive |
| ENSG00000230392.1 |
IPA-3 |
Skin cutaneous melanoma |
0.010780647 |
Sensitive |
| ENSG00000230565.1 |
IPA-3 |
Skin cutaneous melanoma |
0.00492667 |
Sensitive |
| ENSG00000231104.4 |
IPA-3 |
Skin cutaneous melanoma |
0.020760495 |
Sensitive |
| ENSG00000232732.5 |
IPA-3 |
Skin cutaneous melanoma |
0.000443215 |
Sensitive |
| ENSG00000233340.1 |
IPA-3 |
Skin cutaneous melanoma |
0.04784871 |
Sensitive |
| ENSG00000234318.1 |
IPA-3 |
Skin cutaneous melanoma |
0.010373155 |
Sensitive |
| ENSG00000235246.1 |
IPA-3 |
Skin cutaneous melanoma |
0.004277932 |
Sensitive |
| ENSG00000236308.1 |
IPA-3 |
Skin cutaneous melanoma |
0.039502361 |
Sensitive |
| ENSG00000236991.2 |
IPA-3 |
Skin cutaneous melanoma |
0.026377838 |
Sensitive |
| ENSG00000251460.1 |
IPA-3 |
Skin cutaneous melanoma |
0.021058543 |
Sensitive |
| ENSG00000253315.1 |
IPA-3 |
Skin cutaneous melanoma |
0.034827027 |
Sensitive |
| ENSG00000253754.1 |
IPA-3 |
Skin cutaneous melanoma |
0.006729777 |
Sensitive |
| ENSG00000254333.1 |
IPA-3 |
Skin cutaneous melanoma |
0.030061475 |
Sensitive |
| ENSG00000254419.1 |
IPA-3 |
Skin cutaneous melanoma |
0.004322423 |
Sensitive |
| ENSG00000254910.1 |
IPA-3 |
Skin cutaneous melanoma |
0.02480838 |
Sensitive |
| ENSG00000260260.1 |
IPA-3 |
Skin cutaneous melanoma |
0.038009637 |
Sensitive |
| ENSG00000260804.2 |
IPA-3 |
Skin cutaneous melanoma |
0.002097515 |
Sensitive |
| ENSG00000260938.1 |
IPA-3 |
Skin cutaneous melanoma |
0.031297125 |
Sensitive |
| ENSG00000260955.2 |
IPA-3 |
Skin cutaneous melanoma |
0.04569618 |
Sensitive |
| ENSG00000261024.2 |
IPA-3 |
Skin cutaneous melanoma |
0.012500613 |
Sensitive |
| ENSG00000262619.1 |
IPA-3 |
Skin cutaneous melanoma |
0.048482399 |
Sensitive |
| ENSG00000263388.1 |
IPA-3 |
Skin cutaneous melanoma |
0.019572003 |
Sensitive |
| ENSG00000265458.1 |
IPA-3 |
Skin cutaneous melanoma |
0.000497099 |
Sensitive |
| ENSG00000270009.1 |
IPA-3 |
Skin cutaneous melanoma |
0.039847161 |
Sensitive |
| ENSG00000270137.1 |
IPA-3 |
Skin cutaneous melanoma |
0.038296508 |
Sensitive |
| ENSG00000271200.1 |
IPA-3 |
Skin cutaneous melanoma |
0.04768076 |
Sensitive |
| ENSG00000271874.1 |
IPA-3 |
Skin cutaneous melanoma |
0.028573957 |
Sensitive |
| ENSG00000271914.1 |
IPA-3 |
Skin cutaneous melanoma |
0.015722632 |
Sensitive |
| ENSG00000272954.1 |
IPA-3 |
Skin cutaneous melanoma |
0.0089879 |
Sensitive |
| ENSG00000172965.10 |
IPA-3 |
Thyroid carcinoma |
0.02895813 |
Sensitive |
| ENSG00000214049.6 |
IPA-3 |
Thyroid carcinoma |
0.030682266 |
Sensitive |
| ENSG00000215866.3 |
IPA-3 |
Thyroid carcinoma |
0.004605379 |
Sensitive |
| ENSG00000224167.1 |
IPA-3 |
Thyroid carcinoma |
0.003291928 |
Sensitive |
| ENSG00000224468.3 |
IPA-3 |
Thyroid carcinoma |
0.036636678 |
Sensitive |
| ENSG00000224959.1 |
IPA-3 |
Thyroid carcinoma |
0.015049438 |
Sensitive |
| ENSG00000226754.1 |
IPA-3 |
Thyroid carcinoma |
0.03857354 |
Sensitive |
| ENSG00000229874.2 |
IPA-3 |
Thyroid carcinoma |
0.035505308 |
Sensitive |
| ENSG00000230499.1 |
IPA-3 |
Thyroid carcinoma |
0.023728652 |
Sensitive |
| ENSG00000231611.1 |
IPA-3 |
Thyroid carcinoma |
0.020163747 |
Sensitive |
| ENSG00000231999.2 |
IPA-3 |
Thyroid carcinoma |
0.022096503 |
Sensitive |
| ENSG00000236896.1 |
IPA-3 |
Thyroid carcinoma |
0.036027305 |
Sensitive |
| ENSG00000236933.1 |
IPA-3 |
Thyroid carcinoma |
0.019210571 |
Sensitive |
| ENSG00000241288.3 |
IPA-3 |
Thyroid carcinoma |
0.033109988 |
Sensitive |
| ENSG00000242396.1 |
IPA-3 |
Thyroid carcinoma |
0.019731609 |
Sensitive |
| ENSG00000247095.2 |
IPA-3 |
Thyroid carcinoma |
0.035909408 |
Sensitive |
| ENSG00000248890.1 |
IPA-3 |
Thyroid carcinoma |
0.016422214 |
Sensitive |
| ENSG00000254671.1 |
IPA-3 |
Thyroid carcinoma |
0.042679922 |
Sensitive |
| ENSG00000255248.2 |
IPA-3 |
Thyroid carcinoma |
0.028067856 |
Sensitive |
| ENSG00000259877.1 |
IPA-3 |
Thyroid carcinoma |
0.034850397 |
Sensitive |
| ENSG00000260032.1 |
IPA-3 |
Thyroid carcinoma |
0.030311064 |
Sensitive |
| ENSG00000260464.1 |
IPA-3 |
Thyroid carcinoma |
0.013524822 |
Sensitive |
| ENSG00000261338.1 |
IPA-3 |
Thyroid carcinoma |
0.013594459 |
Sensitive |
| ENSG00000266088.1 |
IPA-3 |
Thyroid carcinoma |
0.033224175 |
Sensitive |
| ENSG00000266601.1 |
IPA-3 |
Thyroid carcinoma |
0.004017435 |
Sensitive |
| ENSG00000267476.1 |
IPA-3 |
Thyroid carcinoma |
0.03416963 |
Sensitive |
| ENSG00000269220.1 |
IPA-3 |
Thyroid carcinoma |
0.035480572 |
Sensitive |
| ENSG00000269640.1 |
IPA-3 |
Thyroid carcinoma |
0.047210342 |
Sensitive |
| ENSG00000270062.1 |
IPA-3 |
Thyroid carcinoma |
0.04710283 |
Sensitive |
| ENSG00000270109.1 |
IPA-3 |
Thyroid carcinoma |
0.032289892 |
Sensitive |
| ENSG00000270195.1 |
IPA-3 |
Thyroid carcinoma |
0.019728384 |
Sensitive |
| ENSG00000272142.1 |
IPA-3 |
Thyroid carcinoma |
0.008170602 |
Sensitive |
| ENSG00000272463.1 |
IPA-3 |
Thyroid carcinoma |
0.035907509 |
Sensitive |
| ENSG00000273038.1 |
IPA-3 |
Thyroid carcinoma |
0.045603659 |
Sensitive |
